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Abstract 
Pseudouridines (), the most common modifications in RNA, are formed by stand-alone 
 synthases in all organisms. In addition, archaea and eukaryotes use H/ACA small 
ribonucleoproteins for pseudouridylation. Cbf5, the catalytic component of these 
complexes, can also introduce 55 in archaeal tRNAs in a guide RNA-independent 
manner. Here, kinetic and thermodynamic analyses revealed that both Pyrococcus 
furiosus Nop10 and Gar1 proteins enhance the catalytic ability of Cbf5 and increase its 
affinity for tRNA. Pus10, representing a novel  synthase family, is the in vivo archaeal 
tRNA 55 synthase. Characterization of several Pus10 variants demonstrated the 
importance of the thumb loop for catalysis, a potential role of the THUMP domain in 
tRNA binding and a new catalytic arginine which may flip the target uridine into Pus10’s 
active site. The quantitative characterization of the archaeal pseudouridine synthases 
Cbf5 and Pus10 reported here sheds light on their cellular roles in RNA modification. 
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Chapter 1: Introduction 
1.1 Ribosome biogenesis 
Proteins are indispensable for the survival of living cells and are synthesized by 
macromolecular complexes known as ribosomes. Ribosomes are composed of both RNA 
(~ 60%) and protein (~ 40%). Formation of these macromolecular complexes, a process 
known as ribosome biogenesis, is highly complex and involves synthesis, processing, 
modification of ribosomal RNA (rRNA) and its assembly with proteins. Ribosomes in all 
domains of life are composed of two subunits, a large and a small subunit. Although the 
function of ribosomes in prokaryotes and eukaryotes is conserved, there exist differences 
in their size and complexity. While prokaryotes contain 70S ribosomes composed of a 
30S small subunit and a 50S large subunit, eukaryotes carry 80S ribosomes made up of 
40S and 60S subunits, respectively. Also both the rRNA and protein composition of the 
subunits is slightly different – the prokaryotic 30S subunits contain 16S rRNA and about 
20 ribosomal proteins, while the eukaryotic 40S subunit consists of 18S rRNA and ~ 30 
ribosomal proteins. The prokaryotic 50S subunit comprises two rRNA components (5S 
and 23S) and ~ 30 ribosomal proteins, and the eukaryotic 60S subunits has three rRNAs 
(5S, 5.8S and 25S/28S) along with ~ 45 ribosomal proteins (Wool 1979).  
Although there are differences in the primary structure of rRNAs, the secondary 
structures display significant conservation between prokaryotes and eukaryotes (Lee and 
Gutell 2012). For obvious reasons, all parts of prokaryotic ribosome assembly takes place 
in the same cellular compartment, whereas in eukaryotes, this process occurs in the 
nucleolus for the most part, but also in the cytoplasm (Hadjiolov 1985).   
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1.1.1 Organization of genes encoding ribosomal RNA and proteins  
In bacteria, genes encoding rRNA species are organized into operons (referred to as 
rrn). Seven such transcriptional units are found in Escherichia coli (Kiss et al. 1977). Co-
transcription of these operons results in 30S pre-transcripts consisting of the 16S, 23S, 
and 5S rRNAs (Schlessinger 1980). Spacer regions located in these operons carry genes 
coding for a few transfer RNA (tRNA) molecules. In contrast, eukaryotic rRNA genes 
are arranged into arrays of several tandem repeats (150 – 200 in yeast) each coding for a 
35S pre-transcript containing 5.8S, 18S, and 25S/28S rRNA. Between 150 and 200 
repeats are found on chromosome XII in yeast, accounting for about 10% of the yeast 
genome (Merz et al. 2008). Humans carry about 400 rRNA genes distributed into tens of 
tandem repeats located on chromosomes 13, 14, 15, 21, and 22 (Raska et al. 2004). In 
most eukaryotes, ribosomal genes for 5S rRNA are located separately in large clusters in 
the nucleus (Nazar 2004). A high copy number of rRNA genes ensures that the synthesis 
of ribosomes meets the demand for intensive protein synthesis in dividing cells.  
In addition to the internal spacer sequences separating each rRNA gene, eukaryotes 
also contain both external transcribed and non-transcribed spacer elements (Sylvester et 
al. 2004). Variations in the transcribed spacer sequences contribute to the size and 
composition differences observed in eukaryotic pre-RNA sequences. The secondary 
structures formed by internal spacer sequences appear to be important for interaction with 
the trans-acting factors and in defining the accuracy, efficiency and the order of 
processing steps (Nazar 2004).  
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In prokaryotes, genes coding for ribosomal proteins are found in genomic clusters that 
include several partially conserved operons (Wang et al. 2009). While in eukaryotes, 
ribosomal protein genes are scattered throughout the genome (Kenmochi et al. 1998), 
they are found to be coordinately expressed (Li et al. 2005). Bioinformatic analysis 
revealed that there are 34 ribosomal proteins that are conserved in all domains of life, 
while 33 are conserved only in archaea and eukaryotes; besides these, 1 ribosomal protein 
specific to archaea, 23 specific to bacteria and 11 specific to eukaryotes are observed 
(Lecompte et al. 2002).  
1.1.2. Eukaryotic rRNA processing and ribosome assembly  
In eukaryotes, ribosome biogenesis begins with the transcription of the long pre-rRNA 
by RNA polymerase I in the nucleolus, except for 5S rRNA which is transcribed 
separately by RNA polymerase III in another area of the nucleus (Figure 1.1). Upon 
synthesis, 5S rRNA is transported to the nucleolus as a ribonucleoprotein complex (Nazar 
2004). With the involvement of RNA polymerase II which transcribes the messenger 
RNAs (mRNAs) required for the synthesis of ribosomal proteins and accessory factors, a 
significant portion of the transcription machinery is dedicated to the synthesis of 
ribosomes in rapidly growing cells (Warner 1999).  
Either co-transcriptionally or immediately after transcription, pre-rRNA molecules 
undergo extensive modifications guided by non-coding guide RNAs called small 
nucleolar RNA (snoRNA). The majority of the modifications include 2’-O methylations 
of ribose and isomerization of uridine to pseudouridine guided by C/D box and H/ACA 
box guide RNAs, respectively. Over a hundred guide RNA molecules direct the small 
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nucleolar ribonucleoprotein (snoRNP) complexes to the specific sites in the pre-rRNA for 
modification (for more details refer to section 1.3.2). Initially, a 90S pre-ribosome 
complex is formed in eukaryotes from precursor rRNA transcripts and several ribosomal 
and non-ribosomal proteins (Henras et al. 2008). Next, a number of site-specific pre-
rRNA cleavage steps are carried out by the processing snoRNPs guided by C/D snoRNAs 
U3, U8, U14 and U22, and H/ACA snoRNAs snR10 and snR30 (U17 in mammals) 
(Tollervey and Kiss 1997). Following these steps, further processing occurs by the action 
of exo- and endo-nucleases, which remove the spacer sequences and release the 18S 
rRNA from the pre-transcript. Upon multiple cleavages, these steps result in pre-40S and 
pre-60S ribosomal subunits. Several other intermediates are formed during the 
processing, each with a different subset of proteins.  
Together with nucleases and snoRNPs, there are about 200 accessory factors 
participating in ribosome assembly, which comprise putative ATP-dependent RNA 
helicases, chaperones, GTPases, and export factors (Henras et al. 2008). RNA helicases 
are predicted to be involved in restructuring the RNA, facilitating the ribosomal protein-
RNA interaction and mediating the remodeling of pre-ribosomal complexes (Martin et al. 
2013). Pre-40S and pre-60S complexes are transported from the nucleus to the cytoplasm 
for the final maturation steps (Figure 1.1). This unidirectional transport occurs through 
the nuclear pore complexes with the help of GTPases (Ran or Gsp1p in yeast) and several 
export receptors (Pemberton and Paschal 2005). Finally, further processing of 18S rRNA 
and the replacement of non-ribosomal transport proteins with ribosomal proteins leads to 
the formation of mature and translation-competent ribosomes in the cytoplasm (Henras et 
al. 2008).    
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Figure 1.1. Summary of ribosome biogenesis in eukaryotes 
The long pre-rRNA transcript containing all the rRNAs, except 5S rRNA, is transcribed 
from rRNA gene arrays in the nucleolus. 5S rRNA transcription occurs separately in the 
nucleus. mRNA transcribed from the ribosomal genes in the nucleus is transported to the 
cytoplasm, resulting in the synthesis of ribosomal proteins which are then transported 
back into the nucleolus. Together, all four rRNA species and ribosomal proteins form an 
initial 90S pre-ribosome complex. Several RNA modifications, cleavage events, and 
protein assembly steps take place to form the pre-40S and pre-60S ribosome complexes. 
Following the remodelling of pre-ribosomal complexes, they are transported to the 
cytoplasm for final maturation steps which lead to the formation of mature ribosomes.    
    
Ribosome biogenesis is a highly complicated process with several processing steps 
facilitated by a number of factors, while many proteins responsible for certain processing 
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steps are unknown. Given the dynamic and intricate nature of the steps involved in 
ribosome synthesis, extensive coordination and tight regulation is required between 
rRNA processing and ribosome assembly for maintaining the accuracy in ribosome 
formation which otherwise leads to undesired consequences such as cancer (Montanaro et 
al. 2008). In addition, to efficiently carry out this energy demanding task, eukaryotes also 
exhibit spatio-temporal ordering of the various events involved in ribosome synthesis in 
the nucleolus, nucleoplasm and cytoplasm (Fromont-Racine et al. 2003). Faulty 
ribosomes are found to be eliminated by polyadenylation followed by selective 
degradation by the exosome (Dez et al. 2006).  
1.2 RNA modifications 
1.2.1 Brief introduction to RNA  
RNA, besides DNA and proteins, is an essential biomolecule found in all living cells. 
It replaces DNA in several viruses, acting as the genetic material. Unlike DNA, RNA is 
typically single-stranded and composed of ribonucleotides containing adenine, guanine, 
and cytosine as in DNA, but uracil instead of thymine. Although single stranded in 
nature, RNA can assume various secondary structures through intra-strand base pairing 
and forms complex tertiary structures, which are important for its function (Hermann and 
Patel 1999). In the cell, there are several different types of RNA, most importantly rRNA, 
mRNA, and tRNA. As described in the previous section, rRNA is the major and an 
essential component of the ribosome, which functions as the protein synthesizing 
machinery. mRNA is involved in transferring the genetic information from DNA to 
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proteins, while tRNA works as a molecular adaptor that binds to mRNA, delivering 
amino acids to the site of protein synthesis.   
Human genome sequencing revealed that less than 2% of the cellular DNA is protein-
coding. However, most of the remaining DNA is predicted to actively undergo 
transcription, generating non-coding RNAs (Mattick 2001; Alexander et al. 2010). In 
addition to tRNA and rRNA, several non-coding RNAs were discovered with diverse 
functional abilities. Some of the well studied non-coding RNAs include microRNA 
(miRNA) involved in the regulation of gene expression, small nuclear RNA (snRNA) in 
splicing, small interfering RNA (siRNA) in gene silencing, and snoRNA in RNA 
processing and maturation (Mattick and Makunin 2006). Several other non-coding RNAs 
are emerging, expanding their repertoire of biological functions. Bacteria and archaea 
also contain non-coding RNAs, but they account only for a small fraction of the genomes, 
which correlates with the low complexity of these organisms (Mattick 2001, Costa 2008).  
1.2.2 Modifications in RNA and their significance 
‘RNA modification’ refers to a chemical change applied to the existing nucleotide in 
RNA and does not include variations that lead to the alteration of genetic meaning 
(Grosjean 2005). In the literature, sometimes, ‘RNA editing’, which describes alterations 
such as base substitutions and deletions, is synonymously used with ‘RNA modification’. 
Following transcription, most non-coding RNAs undergo chemical modifications. These 
chemical modifications together with RNA editing and other more complex processing 
steps lead to the maturation of RNA, rendering it functional by attributing to it new 
structural and chemical properties (Grosjean 2005).  The RNA modification database 
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reports 109 different modified nucleotides in RNA with known chemical structures 
(http://rna-mdb.cas.albany.edu/RNAmods/rnaover.htm). tRNA displays the most diverse 
modifications among any known RNA species with 93 different modifications, rRNA 
being the second most commonly modified RNA containing 31 modifications, while 
mRNA provides 13 additional cases and 14 modifications were found in other RNA 
classes such as snRNAs (Cantara et al. 2011). Besides the most prevalent modifications 
(2’-O-methylations and uridine to pseudouridine conversions), RNA contains other 
modifications such as base methylation, base thiolation, base reduction, certain 
hypermodifications (eg. s
2
m
5
U), etc. Both the abundant ribose-methylations and 
pseudouridine formations are introduced by either site-specific enzymes (specific to one 
or more sites) called methylases and pseudouridine synthases, respectively, or by RNA-
guided snoRNP (or just small RNP (sRNP) in archaea) complexes. While only stand-
alone enzymes are found in bacteria, both archaea and eukarya in addition use C/D box 
RNAs to site-specifically guide methylation and H/ACA box RNAs for pseudouridine 
formation. 
 RNA modification is a universal phenomenon displayed in all known RNAs (Lapeyre 
2005). Interestingly, there seems to be a correlation between the number of modifications 
and the complexity of the organism.  For instance, yeast mitochondrial ribosomes, which 
synthesize about 10 proteins, contain 3 modifications in their mitochondrial rRNA, 
compared to over 200 modifications found in rRNA of metazoan ribosomes that 
synthesize thousands of proteins (Lapeyre 2005). The observation that several 
modifications and their sequence locations are conserved, suggests important roles for the 
RNA modifications in the cell. Moreover, modifications mapped onto the three-
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dimensional structure of the ribosome indicated their selective occurrence in functionally 
important regions (Decatur and Fournier 2002; Omer et al. 2003), further supporting their 
importance. Surprisingly, preventing the formation of individual modifications in 
functionally important regions either by knocking out the responsible guide RNA or by 
mutating the enzyme involved in the modification resulted in no or only slight defects. 
But, the absence of these modifications in combination with the removal of modifications 
at other sites displayed effects on growth rate, ribosome formation and translation 
efficiency (King et al. 2003; Liang et al. 2007; Liang et al. 2009). These observations led 
to the hypothesis that the modifications may act in a cooperative manner. 
tRNA displays a clover-leaf secondary structure composed of acceptor stem and T-, 
anticodon-, and D-arms that in turn forms the L-shaped tertiary structure (Figure 1.2). 
The names D- and T-arms in fact originate from the preserved modifications in their loop 
regions, dihydrouridine (D) and ribothymidine (T), respectively. The T-arm is also 
commonly known as the TC-arm due to the presence of a universally conserved 
pseudouridine () at position 55 followed by cytidine in the corresponding loop region. 
Nucleotide modifications found in tRNA stabilize its tertiary structure and prevent it from 
premature degradation (Motorin and Helm 2010). Especially, modifications found in the 
anticodon loop at position 34 and the nearby position 37 are essential for the decoding 
function of tRNA (Satoh et al. 2000).   
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Figure 1.2. Structure of tRNA 
Schematic representation of tRNA secondary structure (left), cartoon representation of 
tertiary structure of yeast tRNA
Phe
 (PDB ID: 4TRA) (right). Key structural elements are 
labeled. Every tenth nucleotide is indicated and the universally conserved 55 is 
highlighted. Single stranded tRNA molecule base-pairs through complementary regions 
forming a cloverleaf secondary structure. The secondary structure shows three stem-
loops, and a stem formed from the base pairing of 3’- and 5’- ends. In addition, tRNA 
also displays a small variable loop. Through coaxial stacking of helices, tRNA forms a 
three dimensional L-shaped structure.  
 
The 2’-O-methylation of ribose stabilizes the C3’-endo form of ribose resulting in 
conformational rigidity (Kawai et al. 1992), contributing to the tRNA function in codon 
recognition and protecting the RNA from unspecific degradation (Motorin and Helm 
2010). Methylations are linked to the thermal stability of tRNA and rRNA in 
hyperthermophiles (Kowalak et al. 1994; Noon et al. 1998), and to the conferral of 
resistance against antibiotics (Douthwaite et al. 2005). It was also proposed that the 
methylations clustered on the exit tunnel of the ribosome provide a hydrophobic 
environment that may prevent the nascent polypeptides from sticking to the tunnel 
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(Nissen et al. 2000). Together these observations underline both the structural and 
functional importance of modifications in RNA.    
1.2.3 Pseudouridine  
1.2.3.1 Structure and important properties of pseudouridine 
Initially, RNA was believed to be composed of four canonical nucleotides. Research 
conducted in the early 1950s using ribonuclease-digested yeast RNA extract led to the 
isolation of a minor RNA constituent that was referred to as the ‘fifth nucleotide’ (Davis 
and Allen 1957). As this newly identified nucleotide (5-ribosyluracil) exhibited similar 
physical and chemical properties to the canonical uridine (1-ribosyluracil), it was named 
‘pseudouridine’, and abbreviated ‘' (Cohn 1959). Further analysis of this compound 
revealed that it is a uridine derivative with an unusual C-C glycosidic bond, instead of the 
typical N-C glycosidic bond (Figure 1.3) (Cohn 1960). It has been proposed that the 
isomerization of uridine to involves breakage at N1-C1’, followed by a rotation around 
the N3-C6 axis, with the concomitant formation of a new glycosidic bond between C5 and 
C1’ (Goldwasser and Heiniukson 1966). 
Despite similarities to its parent uridine nucleotide, displays a few distinct 
properties attributing to it certain advantages over a uridine in RNA (Figure 1.3). Its 
unique C-C glycosidic linkage is predicted to provide enhanced conformational flexibility 
over the N-C glycosidic bond through increased rotational freedom about the C-C link 
(Lane et al. 1995). With this increased rotational flexibility,  was thought to have a 
preference for the syn glycosyl conformation over the anti conformation found in uridine, 
suggesting a role for  as a ‘conformational switch’ in RNA (Neumann et al. 1980). 
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While this was shown to be the case with the free nucleoside, in RNA however,  has 
been found to always exist in the anti conformation (Yarian et al. 1999). In the anti 
conformation, maintains the ability to base pair with an adenine nucleotide like uridine. 
 
Figure 1.3. Isomerization of uridine to pseudouridine. 
Pseudouridine is introduced at specific sites in RNA by pseudouridine synthase. The two 
important differences found in pseudouridine compared to uridine are the C-C glycosidic 
bond and an extra -NH group that can participate in a new hydrogen bond.    
The other important feature is the extra N1H imino group in which has the potential 
to participate in an additional hydrogen bond, establishing novel interactions in RNA 
(Figure 1.3). tRNA co-crystallized with a tRNA synthetase revealed a water molecule 
linking the  to the phosphate backbone through hydrogen bonding with N1H of and 
the 5’ phosphate of the same residue (Arnez and Steitz 1994). Through this novel 
hydrogen bond,  stabilizes the local structure of RNA resulting in  increased rigidity 
(Yarian et al. 1999). In addition to the structural stabilization by extra hydrogen bonding, 
studies conducted using model RNA oligonucleotides containing demonstrated that 
increases local RNA stacking by promoting a 3’-endo conformation of ribose (Davis 
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1995). This also increases the base stacking in neighboring nucleotides in a cooperative 
manner contributing to increased stability of RNA structure. Consistent with these 
observations,  has been shown to enhance the thermal stability of RNA (Arnez and 
Steitz 1994).         
1.2.3.2 Distribution of  in RNA and its biological significance  
s are the most abundant individual modifications observed in RNA. They are 
distributed in all three domains of life in many non-coding RNAs, such as tRNA, rRNA, 
snRNA and snoRNA (Charette and Gray 2000). They are very common in tRNA; 
especially, at position 55 is found in all tRNAs with the exception of few initiator 
tRNAs (Samuelsson et al. 1987). s are also commonly encountered in the anticodon 
stem-loop (38, 39) and the D-arm (13) of tRNA. Although less common, they are 
also found at other sites in tRNA in a phylogenetic domain specific manner (Auffinger 
and Westhof 1998). Most of the conserved s tend to be located at the stem and loop 
junctions, owing to the stabilizing effect that  has on these structural motifs (Charette 
and Gray 2000). Grosjean and colleagues have demonstrated that 38 and 39 in  tRNAs 
play a role in enhancing stop codon readthrough and +1 frame shifting in yeast (Lecointe 
et al. 2002).s introduced at multiple sites in eukaryotic tRNA by pseudouridine 
synthase 1 (Pus1) are predicted to play an important role in nuclear export of tRNA 
(Grosshans et al. 2001). Notably, it has been shown that 55 regulates the modifications 
at the other sites in tRNA, in particular Gm18, m
5
s
2
U54, and m
1
A58 for low-temperature 
adaptation in Thermus thermophilus (Ishida et al. 2011). Together with other 
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modifications in tRNA, s take part in fine-tuning the tRNA structure that in turn 
influences codon reading and the accuracy of protein synthesis (Harrington et al. 1993).  
As discussed in section 1.1, rRNA undergoes extensive chemical modifications during 
rRNA processing and its assembly into the ribosome. s are ubiquitous in both small and 
large subunit rRNAs. It appears that the number of s increases with the complexity of 
the organism. While E. coli rRNA contains only 11 such modifications, rRNA from yeast 
and humans show around 50 and 100 s, respectively (Ofengand 2002). s are found to 
cluster in functional centers of  the ribosome, corresponding to the peptidyl transferase 
center, the decoding center (site for interaction of tRNA with mRNA), the peptide exit 
tunnel and also the interface of large and small subunits of the ribosome (Charette and 
Gray 2000; Decatur and Fournier 2002). Based on their prevalence in functional sites, s 
in rRNA are predicted to stabilize local RNA structure through RNA-RNA and RNA-
protein interactions and to play an important role in ribosome biogenesis and ribosome 
function (Charette and Gray 2000). In accordance with this prediction, blocking the 
formation of a conserved  (position 2920) in the A-site of the peptidyl transferase center 
in yeast rRNA resulted in a reduced translation rate and impaired polysome formation 
(King et al. 2003). In E. coli, three s at positions 1911, 1915, and 1917 are found in 
helix 69 of the 23S rRNA, which forms a bridge between the large and small ribosomal 
subunits. Loss of these modifications in bacteria by deleting RluD, the pseudouridine 
synthase responsible for their formation, revealed that these s play an important role in 
translation termination and peptide release by influencing the activity of releasing factor 
2 (Kipper et al. 2011). Extensive analysis of modifications in yeast rRNA by the Fournier 
lab further demonstrated that conserved s in helix 69 of eukaryotic ribosomes play 
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broader roles, influencing ribosome formation, stability, and function (Liang et al. 2007). 
Depletion of s in combination with methylations in the decoding center of the yeast 
ribosome resulted in reduced translational activity and defects in synthesis of the 
ribosomal small subunit (Liang et al. 2009). A common observation made in all these 
studies is that a minimal or null effect is observed upon removal of a single modification, 
while deletion of modifications at 3 or more sites from the same region showed 
significant effects indicating that the modifications act cooperatively.  
In eukaryotes, small nuclear RNA (snRNA) combines with proteins to form ‘small 
nuclear ribonucleoprotein complexes’ (snRNPs) referred to as the ‘spliceosomal 
machinery’. These complexes are responsible for splicing non-protein coding introns 
from eukaryotic pre-mRNA resulting in mature mRNA containing protein-coding exons. 
All major spliceosomal RNAs (U1, U2, U4, U5 and U6) display extensive 
pseudouridylation. Notably, Xenopus U2 snRNA contains 13 s, accounting for 12% of 
its nucleotides and 60% of the total RNA modifications found in this RNA (Reddy and 
Busch 1988). In contrast, few s are found in minor spliceosomal RNAs. As in rRNA 
and tRNA, many of these s in spliceosomal RNAs are conserved across species and are 
found in functionally important regions (Karjolich and Yu 2010). The significance of s 
in snRNAs is not well understood except for their importance in U2 snRNA. Using a 
reconstituted system from Xenopus oocytes, Zhao and Yu (2004) demonstrated the 
essential role of s in branch site recognition region by U2 snRNA in the assembly of 
functional spliceosome and pre-mRNA splicing. Loss of 35 in the branch site sequence 
from U2 snRNA when coupled with either a substitution of uridine to guanine at position 
40 or deletion of the uridine, leads to the accumulation of pre-mRNA and results in a 
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temperature-sensitive growth phenotype in yeast (Yang et al. 2005). found in U5 
snRNA has been shown to participate in binding the pre-mRNA, suggesting a role for 
this residue in stabilizing the interaction between U5 snRNA and pre-mRNA (Karjolich 
and Yu 2010). Interestingly, recent studies performed with yeast subjected to nutrient 
deprivation and heat shock, revealed the induced formation of s at novel sites in U2 
snRNA, indicating a probable regulatory role for s under stress conditions (Wu et al. 
2011).  
s have not yet been reported to naturally exist in mRNAs, owing to the low 
abundance of mRNAs compared to rRNAs and tRNAs, which makes it difficult to 
analyze their modifications. However, several studies point towards the possibility of 
widespread s in mRNA (Ge and Yu 2013). Studies using artificial H/ACA RNAs 
indicated that mRNA can in principle be pseudouridylated at target sites (Chen et al. 
2010). Interestingly, when uridine present in nonsense codons is subjected to 
pseudouridylation, it suppresses translation termination (Karjolich and Yu 2011). Further, 
Kariko and colleagues have shown that pseudouridylation of in vitro transcribed mRNA 
increases translation by decreasing the activation of RNA-dependent protein kinase 
compared to uridine containing mRNA (Anderson et al. 2010). Increased translational 
efficiency combined with reduced immunogenicity observed due to  incorporation 
makes mRNA containing s a potential choice in RNA-based therapeutic applications 
(Anderson et al. 2010). Together, all these findings suggest that s are selected in 
evolution to play important roles in diverse RNA species, particularly by stabilizing the 
structural motifs present in functional centers, thereby influencing several key cellular 
activities in all domains of life.  
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was shown to be metabolized in E. coli using a pseudouridine kinase 
(phosphorylates ribose) and pseudouridine-5’-phosphate glycosidase (hydrolyzes the 
unique C-C glycosidic bond in releasing uracil and ribose-5’-phosphate (Preumont et 
al. 2008). Like other nucleotides, this study indicated that can be recycled for efficient 
use of cellular components. Notably, homologs of these enzymes are found in most 
eukaryotes, but not in mammals.  
1.3  synthases  
As discussed above, s are extensively distributed in almost all RNA classes and are 
important for several cellular activities. In all domains of life, specific uridines in RNA 
are isomerized to s by a group of enzymes known as ‘ synthases’. Although bacteria 
use protein-only  synthases (hence referred to as stand-alone  synthases), archaea and 
eukaryotes employ RNA-dependent protein complexes to accomplish this task in addition 
to stand-alone enzymes. 
1.3.1 Stand-alone  synthases 
Johnson and Söll (1970) at Yale University were first to demonstrate pseudouridine 
synthase activity in E. coli extracts using [
14
C] labeled in vitro transcribed tRNA. Their 
experiments revealed that s are specifically derived from existing uridines in RNA by 
enzyme(s) present in an E. coli cell extract. Studies based on observations that s are 
absent from the anticodon loop of tRNA
His
 in bacterial hisT (a gene found in the histidine 
operon) mutant strains led to the discovery and characterization of the first bacterial 
pseudouridine synthase (pseudouridine synthase I), the product of the hisT gene (Cortese 
 18 
et al. 1974; Marvel et al. 1985). A  decade later, the Ofengand and Lane labs together 
purified and characterized bacterial 55 synthase, which they named TruB (for tRNA 
pseudo U modification), renaming the previously identified  pseudouridine synthase I as 
TruA (Nurse et al. 1995). Continued efforts to identify the other  synthases using 
bioinformatic and various biochemical approaches resulted in the discovery of several 
synthases in bacteria and eukarya. Knowledge of synthases in archaea lags behind 
with only a handful of them having been characterized so far (Grosjean et al. 2008; Blaby 
et al. 2011).  
1.3.1.1  synthase families and their structural organization 
On the basis of sequence similarity, synthases are grouped into six families (Table 
1.1) (Hamma and Ferré-D'Amaré 2006; McCleverty et al. 2007). Each of these families 
is named after its E. coli representative. The only exception to this is Pus10, a recent 
addition to the synthase families with no known homologs in bacteria, which is named 
after the archaeal enzyme (Roovers et al. 2006). Representative crystal structures of all 
six synthases families have been solved (Foster et al. 2000; Hoang and Ferré-D'Amaré 
2001; Sivaraman et al. 2002; Hoang and Ferré-D'Amaré 2004; Phannachet et al. 2005; 
Hoang et al. 2006; McCleverty et al. 2007). Comparative analysis of these structures 
revealed that despite the lack of sequence similarity, all synthases display a common 
catalytic fold and a conserved active-site structure (Figure 1.4). The core architecture 
unique to synthases consists of an extended platform of eight continuous mixed -
sheets with several helices and loops surrounding them. The center of the platform acts as 
an active-site cleft flanked by a conserved loop-helix structure on one side and a long 
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loop on the other side. This long loop contains a strictly conserved aspartate residue, 
referred to as the catalytic aspartate, found in all synthases.  
Table 1.1.  synthase families with representative enzymes 
Family 
Name 
Accessory 
domain 
Example: substrate specificity of enzyme 
naming the family 
Substrate 
Modification 
sites 
Organism 
TruA None tRNA 38, 39, 40 E. coli 
TruB PUA (C-
terminal) 
tRNA 55 E. coli 
RluA S4-like domain*  
(N-terminal) 
tRNA 32 E. coli 
23S rRNA 746 E. coli 
RsuA S4-like domain 
(N-terminal) 
16S rRNA 516 E. coli 
TruD TruD tRNA 13 E. coli 
Pus10 THUMP 
 (N-terminal) 
tRNA 55 P. furiosus 
* The accessory domain is absent in the enzyme RluA but found in other members 
of the family 
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Figure 1.4. Structures of representative  synthases.  
Cartoon representation of a representative structure from each of the six families of 
synthases. E. coli TruA (1DJ0), TruB (1K8W), RluA (2I82), RsuA (1KSK), TruD 
(1SZW), and human Pus10 (2V9K). The catalytic domain of each protein is shown in the 
same orientation and in a single color (blue), while the accessory domains are colored 
differently (TruA additional subunit: pink, PUA: magenta, S4: grey, TruD: olive, 
THUMP: green) and labeled. The catalytic aspartate in the catalytic pocket is highlighted 
in red.  
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synthases show diverse secondary structural insertions adjacent to the catalytic site. 
While TruB has a thumb-like insertion on one side of the catalytic pocket, RluA, in 
addition to the thumb loop, contains a forefinger loop on the other side of the catalytic 
pocket. These loops are believed to play an important role in interaction with RNA 
(Hamma and Ferré-D'Amaré 2006). Besides the catalytic domain, most of the 
pseudouridine synthases have distinct accessory domains appended either at the N- or C- 
terminus of the protein (Table 1.1). While the TruB family exhibits a C-terminal PUA 
domain (named after its presence in some PseudoUridine synthases and Archaeosine-
transglycosylases) (Hoang and Ferré-D'Amaré 2001), some members of the RluA 
(referring to Ribosomal large subunit) and RsuA (Ribosomal small subunit) families 
contain an N-terminal domain similar to the one in ribosomal protein S4 (Hamma and 
Ferré-D'Amaré 2006). These accessory domains are predicted to facilitate RNA binding. 
An interesting observation was made from a crystal structure of E. coli TruD, wherein the 
catalytic domain of this enzyme displays a circular permutation of the secondary 
structural elements (Hoang and Ferré-D'Amaré 2004), besides an additional TruD 
specific domain inserted into its catalytic domain (Figure 1.4). In contrast to all other 
synthases, only TruA functions as a dimer (Hur and Stroud 2007).  
Based on the conserved catalytic core found in all synthases, these enzymes are 
predicted to be evolved from a common ancestor through divergent evolution (Mueller 
2002; Hur et al. 2006). Among all synthase families, TruD shows the lowest sequence 
similarity to other families and has homologs in all domains of life indicating that it could 
have diverged first from other synthases, followed by TruA (Hamma and Ferré-
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D'Amaré 2006). RluA and RsuA are relatively similar sharing three conserved motifs 
(Motifs I, II, and III), along with TruB, which shares motif I and II (Koonin 1996).    
1.3.1.2 Substrate recognition and catalysis 
RNA targets of synthases vary from simple RNA stem-loops to long rRNA 
molecules with complex three-dimensional structures. synthases display diverse 
specificity with respect to the number of modification sites and types of RNAs modified 
(Table 1.1). Some of them modify only a specific site in a single class of RNA; for 
example, so far RsuA has only been shown to introduce at position 516 in 16S rRNA 
(Wrzesinski et al. 1995). Others modify several sites in structurally similar regions in 
multiple RNAs of the same type. TruB, also known as 55 synthase, modifies uridine at 
position 55 in almost all bacterial tRNAs (Nurse et al. 1995). TruA on the other hand is 
responsible for modifying three different nearby sites (38, 39, and 40) in the same tRNA 
(Hur and Stroud 2007). Furthermore, some enzymes are able to modify different 
positions in entirely different classes of RNA. For instance, RluA pseudouridylates a 
single uridine in tRNA (U32) as well as in rRNA (U746 in 23S rRNA) (Wrzesinski et al. 
1995).  
synthases employ different approaches to recognize the target uridine in RNA, 
either in the context of structure or sequence. In the case of TruB, RNA recognition takes 
place mainly by shape complementarity, wherein the enzyme recognizes the native 
structure of the T-loop containing the modification site (Hoang and Ferré-D'Amaré 
2001). Further, to enhance specificity, TruB also makes contact with a few conserved 
nucleotides in the substrate, such as the C56 located close to the target site (Hamma and 
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Ferré-D'Amaré 2006). RluA on the other hand induces a structural reorganization in the 
anticodon loop containing the target U32 nucleotide, subsequently recognizing this newly 
formed structure through shape complementarity (Hoang et al. 2006). In contrast to the 
two strategies used by TruB and RluA, TruA establishes an interaction with two 
conserved tRNA structural elements (elbow and the D stem) with the help of an 
additional subunit forming the homodimer, thereby recognizing the dynamic anticodon 
loop containing the three target sites located in a row (Hur and Stroud 2007). While RluF, 
a member of RsuA family has been shown to follow a similar approach to RluA in 
identifying the target uridine (Alian et al. 2009), substrate interactions of TruD and Pus10 
is not well understood. In addition to all these mechanisms used in substrate recognition, 
Cbf5, a TruB family synthase, uses a completely different strategy by employing a 
guide RNA to recognize the target substrate (see section 1.3.2 for details). In all of these 
modification events, in order to gain access to the target site, usually the target uridine is 
flipped out from the RNA into the active site of the enzyme, with up to  two additional 
bases undergoing base-flipping (Hamma and Ferré-D'Amaré 2006). 
Bioinformatic and structural studies revealed five signature motifs present in the 
catalytic domains of synthases, motif I, II, IIa, III and IIIa (Koonin 1996; del Campo et 
al. 2004; McCleverty et al. 2007). The catalytic pocket of synthases is largely 
hydrophobic in nature and harbours three conserved active site residues. Besides the 
invariant aspartate residue located in motif II, a tyrosine (replaced by phenylalanine in 
TruD) in motif IIa, and a basic residue, either arginine or lysine in motif III, are found in 
the active site of synthases (Hamma and Ferré-D'Amaré 2006). Structural and 
biochemical analyses have confirmed the critical role of the aspartate residue in catalysis 
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(Ramamurthy et al. 1999; Hoang et al. 2005). The conserved tyrosine/phenylalanine 
(Y179 in TruB) is involved in a stacking interaction with the target base and is proposed 
to act as a general base in a later step of the catalytic reaction (Phannachet et al. 2005). 
The arginine or lysine (R181 in TruB) makes a salt bridge with the aspartate and it might 
play a role in positioning the aspartate for catalysis (Pan et al. 2003).  Besides these 
conserved active site residues, except TruB and TruD, the other four synthase families 
contain an arginine residue two nucleotides prior to the catalytic aspartate.  TruB, on the 
other hand has a histidine five nucleotides prior to the catalytic aspartate. Cocrystal 
structures of TruB and RluA have shown that these histidine and arginine residues 
occupy the location vacated by the flipped-out target nucleotide in tRNA, respectively 
(Hoang and Ferré-D'Amaré 2001; Hoang et al. 2006).   
Despite significant knowledge of the structure and substrate recognition by 
synthases, the actual chemical mechanism of  formation is unknown. The same 
catalytic fold and the conserved active-site structure of synthase families suggest that 
all synthases likely employ a common catalytic mechanism. In support of this 
hypothesis, kinetic analysis of E. coli TruB, TruA, and RluA by our lab revealed that all 
three studied enzymes have very similar rate constants with a uniformly slow catalytic 
step (Wright et al. 2011). Some mechanistic insight has been obtained using a 5-
fluorouridine (5-FU) substituted RNA to probe the chemical steps occurring during 
formation (Gu et al. 1999; Hoang and Ferré-D'Amaré 2001). At minimum, formation 
involves three chemical steps; breakage of the N1-C1’ glycosidic bond, rotation of the 
detached base, and reattachment of the base to form a new glycosidic bond between C5 
and C1’ (Hamma and Ferré-D'Amaré 2006). Three catalytic mechanisms have been 
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proposed based on different roles of the catalytic aspartate. According to the first 
mechanism (Gu et al. 1999), the aspartate residue attacks the C6 of the uracil base in a 
Michael addition forming an ester intermediate (Michael adduct) (Figure 1.5). Base 
rotation takes place around the ester bond while the uracil is attached to the enzyme, 
followed by hydrolysis of the ester linkage resulting in According to the second 
mechanism (Huang et al. 1998), the aspartate carries out a nucleophilic attack onto C1’ of 
ribose generating an acylal intermediate (Figure 1.5). The liberated base then undergoes a 
rotation allowing the new C-C glycosidic bond formation.  
 
Figure 1.5. Potential intermediates formed during  formation 
The three mechanisms proposed to explain  formation proceed through different 
intermediates. 1. Michael adduct is generated during the nucleophilic attack at C6 of 
uracil by the catalytic aspartate. 2. Acylal intermediated forms when the nucleophilic 
attack occurs at C1’ of ribose 3. Proton abstraction from C2’ of ribose produces a glycal 
intermediate.   
More recently, a third mechanism has been proposed by the Mueller group based on 
the observation of two isomeric hydrated products formed when a 5-FU containing tRNA 
is incubated with TruB (Miracco and Mueller 2011). According to this mechanism, the 
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reaction proceeds through a glycal intermediate produced as a result of the abstraction of 
a proton by the aspartate from C2’ of ribose. This study rules out the Michael addition 
mechanism, but is also in accordance with the mechanism containing an acylal 
intermediate. Further studies are required to clarify the exact mechanism involved in 
formation by synthases. 
1.3.2 H/ACA small ribonucleoprotein complex  
As mentioned earlier, isomerization of uridine to is also performed by H/ACA 
sRNP or snoRNP complexes in archaea and eukaryotes, respectively. H/ACA RNAs 
were first reported by the Fournier group as a new major class of RNA besides C/D box 
RNAs in the nucleolus of yeast and vertebrates (Balakin et al. 1996). Whereas the C/D 
box RNAs function in guiding the site-specific methylation of ribose, H/ACA box RNAs 
are involved in the pseudouridylation process (Ni et al. 1997). Although they mainly 
guide rRNA and snRNA pseudouridylations, there is one case reported in archaea where 
they could guide tRNA modification (Muller et al. 2009). H/ACA RNAs involved in 
guiding snRNA modifications are known as small Cajal body specific RNAs (scaRNAs) 
owing to their localization in Cajal bodies (Darzacq et al. 2002). Cajal bodies are 
dynamic nuclear regions found in eukaryotes and are the centers for the biogenesis of 
snRNPs involved in splicing. To perform site-specific pseudouridylation, H/ACA RNA 
forms a complex with a set of four evolutionarily conserved proteins consisting of a 
catalytic component, Cbf5 (dyskerin in humans) and three accessory proteins, Nop10, 
L7Ae (Nhp2 in eukaryotes) and Gar1.  
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1.3.2.1 H/ACA snoRNAs 
H/ACA RNAs are typically 70 - 250 nucleotides long and adopt a 5’-hairpin-hinge-
hairpin-tail-3’ secondary structure (Figure 1.6A) (Balakin et al. 1996). The eukaryotic 
snoRNAs usually have a two-stem H/ACA RNA with a hinge region connecting them. 
Although single hairpins are common in archaea, they also have two and three hairpin 
structures (Omer et al. 2003). In eukaryotes, a set of core proteins are proposed to bind 
each hairpin region and may direct the pseudouridylation of two distantly spaced uridines 
in rRNA (Watkins et al. 1998; Kiss et al. 2010). All H/ACA RNAs show two 
characteristic conserved sequences, box ‘H’ referring to the sequence in the hinge region 
(ANANNA, where N is any nucleotide) and ‘ACA’ (ANA in archaea) referring to the 
sequence found in the tail region, exactly three nucleotides upstream of the 3’-end of the 
RNA. In each hairpin structure at the junction of two stem regions, there is an internal 
loop called the ‘pseudouridylation pocket’ with 9-13 nucleotides on each strand 
(Reichow et al. 2007). The pseudouridylation pocket displays complementarity to a 
specific sequence in the substrate RNA, allowing base pairing to position the unpaired 
target uridine at the base of the upper stem for modification. The distance between the 
target uridine and the conserved H or ACA box elements is typically between 14 and 17 
nucleotides (Ni et al. 1997). A kink-turn, a common structural motif found in RNA, is 
formed by a 3-nucleotide bulge flanked with non-canonical GA base pairs on one side 
and canonical GC base pairs on the other side (Klein et al. 2001). Archaeal, but not 
eukaryotic H/ACA RNAs, contain a kink-loop (a variant of kink-turn) in the upper half of 
the stem, where the accessory protein L7Ae binds (Rozhdestvensky et al. 2003). A kink-
loop is similar to a kink turn, but lacks canonical stem. 
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1.3.2.2 Structure and function of H/ACA sRNP complex  
In vitro reconstitution of H/ACA sRNPs from archaea (Baker et al. 2005; Charpentier 
et al. 2005) and the crystal structures of various subcomplexes as well as complete 
H/ACA sRNP with and without substrate (Hamma et al. 2005; Li and Ye 2006; Rashid et 
al. 2006; Duan et al. 2009; Liang et al. 2009) provided a deeper insight into their 
structural organization and function. The catalytic component, Cbf5, is a TruB family  
synthase and contains an N-terminal catalytic domain and a large C-terminal PUA 
domain with N- and C-terminal extensions compared to TruB. Cbf5 specifically 
recognizes the conserved 3’-ACA sequence of H/ACA RNA and interacts with the lower 
stem of the hairpin through the PUA domain (Figure 1.6B). Nop10 forms extensive 
contacts with Cbf5 and also binds the upper stem of the H/ACA RNA hairpin, whereas 
Gar1 exclusively binds to Cbf5 at a distant region, especially to Cbf5’s thumb loop which 
is involved in substrate RNA binding (see below). In contrast, L7Ae interacts with the 
kink-loop in the upper stem region of archaeal H/ACA sRNA and also makes few 
contacts with Nop10. Substrate RNA is recruited into the pseudouridylation pocket 
through base pairing to one side of the guide RNA forming a U-shaped substrate 
structure. Substrate binding induces a conformational reorganization of the 
pseudouridylation pocket and influences the two flanking stems of the guide RNA 
thereby positioning the target uridine in the active site of Cbf5. In the absence of 
substrate, the thumb loop of Cbf5 assumes an open conformation by binding to Gar1, but 
upon substrate recruitment the thumb loop establishes an interaction with the substrate 
RNA, stabilizing it in the active site (closed conformation) (Duan et al. 2009). The 
interaction of Gar1 with the thumb loop was suggested to play a role in sensing the 
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successful modification allowing the concomitant release of the product. The yeast 
H/ACA snoRNP complex has also been successfully reconstituted and its crystal 
structure has been determined, which revealed a similar structural organization of the 
yeast H/ACA snoRNP complex and the archaeal complex (Li et al. 2011).   
 
Figure 1.6. Structure of H/ACA guide RNA and snoRNP complex 
A. Schematic diagram of H/ACA guide RNA showing a two-hairpin H/ACA guide RNA 
with the conserved box H and ACA motifs. The pseudouridylation pocket is the site for 
substrate binding, and the kink-loop is found in the upper stem of archaeal guide RNAs 
where L7Ae binds. B. Cartoon representation of the structure of a single-hairpin H/ACA 
guide RNA (yellow, pseudouridylation pocket in orange and 3’-ACA in red) from P. 
furiosus bound to all four H/ACA proteins (Cbf5 in blue, Nop10 in pink, Gar1 in orange, 
and L7Ae in cyan) in the absence of substrate RNA (PDB ID 2HVY). H and ACA motifs 
in RNA and the catalytic aspartate in Cbf5 are highlighted in red and green, respectively.   
 
Recently, Yang and colleagues reported the kinetic and thermodynamic analysis of the 
archaeal H/ACA sRNP complex (Yang et al. 2012). Based on the data obtained using 
fluorescence correlation spectroscopy, they proposed a two-step sequential model for 
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substrate binding and product release. The substrate initially binds the guide RNA 
through base pairing, and is then recruited into the active site by interacting with the 
thumb loop of Cbf5. Following  formation, the thumb loop undergoes a conformational 
change, thereby releasing the product RNA. In this work, the authors also reported a dual 
role for Gar1, both in catalysis and in product release. Further evaluation is required to 
test if the binding and kinetic parameters reported in this work are relevant since 
experiments were conducted at 27 ˚C as opposed to the reported optimal temperature (70 
˚C) for P. furiosus Cbf5.  
In addition to the major function of the H/ACA sRNP complex in  formation in 
multiple substrates, they also play other important roles in eukaryotes.  Some H/ACA 
snoRNAs are involved in rRNA processing (see section 1.1). For instance, snR30 from 
yeast base pairs to short internal sequences in 18S rRNA and is believed to guide pre-
rRNA processing factors essential for the nucleolytic cleavage of 18S rRNA from 35S 
pre-rRNA (Tollervey and Kiss 1997) 
Telomerase is an essential eukaryotic enzyme that adds nucleotide repeats to the 
telomere, maintaining its length. Telomerase is composed of telomerase reverse 
transcriptase (TERT) and an RNA component (TERC) that acts as a template for the 
DNA extension. Notably, mammalian TERC contains an H/ACA domain that is essential 
for telomerase function and localization (Collins 2006). Similar to the H/ACA snoRNP 
complexes guiding pseudouridylation, the telomerase RNA H/ACA domain also forms a 
complex with the same four core proteins (Dez et al. 2001), but there are no known 
pseudouridylation targets of this complex.  
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Dyskeratosis congenita (DC) is an inherited rare bone marrow failure syndrome with 
the affected patients showing defects in telomerase function. DC is genetically 
heterogenous with the causative mutations found in human Cbf5 (dyskerin), NOP10, 
NHP2, TERC and TERT and in a telomere protecting protein (Tin2) (Kirwan and Dokal 
2009). One of the most common and severe X-linked forms of this syndrome is caused by 
mutations in the PUA domain at the binding interface of H/ACA snoRNA and dyskerin 
(Rashid et al. 2006), implying that RNA binding is impaired. DC mutations in dyskerin, 
NHP2 or NOP10 are reported to affect the assembly of H/ACA snoRNP complexes 
(Trahan et al. 2010). Although initial studies from animal models suggested that defects 
in ribosome biogenesis and function due to mutations in dyskerin are likely responsible 
for DC, current studies favour the effects on telomerase as the principal factor leading to 
DC (Kirwan and Dokal 2009).  
1.3.2.3 Eukaryotic H/ACA snoRNP biogenesis  
snoRNA genes show variation in organizational structure. In archaea and yeast, they 
are mostly encoded by independent genes organized into mono- or polycistronic 
transcriptional units. In contrast, in higher eukaryotes, most of them are encoded in 
intronic regions of protein-coding or non-coding genes (Kiss et al. 2010). The proteins 
expressed from these host genes are usually involved in ribosome biogenesis and 
function, indicating the coordination between the synthesis of snoRNAs and ribosome-
associated factors (Filipowicz and Pogacic 2002). snoRNAs transcribed from 
polycistronic genes are processed by endonucleases to liberate individual snoRNAs. 
Intronic snoRNAs are either generated by canonical splicing or by the action of specific 
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endonucleases that remove non-snoRNA regions (Filipowicz and Pogacic 2002). The 5’ 
and 3’ ends of the snoRNAs are then trimmed by exonucleases.  
The H/ACA snoRNP precursor assembly process begins co-transcriptionally in the 
nucleoplasm. In addition to the nucleoplasm, snoRNP biogenesis takes place in Cajal 
bodies with the accumulation of final mature snoRNPs in the nucleolus (Watkins and 
Bohnsack 2012). The conserved box elements and the stem structures of H/ACA RNA 
play an essential role in the snoRNP assembly and are thus important for the snoRNA 
stability and localization (Filipowicz and Pogacic 2002). Assembly of H/ACA snoRNP 
complex starts with the assembly factor Shq1 binding to Cbf5, which may assist the 
recruitment of Nop10 and Nhp2, forming a ternary complex of Cbf5-Nop10-Nhp2 
(Grozdanov et al. 2009). Naf1, another recruiting factor binds Cbf5 in the ternary 
complex (Ballarino et al. 2005; Kiss et al. 2010). Interaction of Shq1 and Naf1 is thought 
to stabilize Cbf5 and to ensure its correct subcellular localization (Darzacq et al. 2006). 
By interacting with the C-terminal domain of RNA polymerase II, Naf1is suggested to 
guide the Cbf5-Nop10-Nhp2 complex to the nascent H/ACA snoRNA (Yang et al. 2005). 
In the final step of the assembly, Naf1, which has a domain similar to Gar1, is replaced 
by Gar1 resulting in the final mature complex composed of H/ACA snoRNA and Cbf5-
Nop10-Nhp2-Gar1 complex. In addition to the specific assembly factors discussed, the 
survival of motor neuron (SMN) complex, general assembly factors such as Hsp90 and 
several other unknown trans-acting factors are believed to assist in this complex and 
dynamic H/ACA snoRNP biogenesis process (Kiss et al. 2010).  
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1.4 Objectives 
As summarized in this chapter, s are universally distributed in non-coding RNAs 
from all domains of life and are important in several essential processes in the cell. 
Although significant insight has been obtained into this most common RNA 
modification, several questions remain to be answered, such as: How do synthases that 
specifically recognize one or two target sites function compared to the synthases with 
more targets? Is there any order in the occurrence of  modifications in the cell? If so, 
how does the cell regulate  synthases to coordinate the modification at multiple target 
sites in a prioritized manner? Even more challenging questions to tackle are, what is the 
chemical mechanism involved in  formation and what is the biological significance of 
s in RNA? 
To address these complex problems, smaller questions that are an integral part of these 
challenges need to be identified and answered first, which will ultimately guide us 
towards a comprehensive understanding of  formation. With this approach in mind, in 
this thesis questions have been asked regarding Cbf5, a complex enzyme acting as part of 
the H/ACA sRNP complex, and Pus10, a new stand-alone synthase. Both of these 
enzymes have been shown to be involved in the pseudouridylation of U55 in archaeal 
tRNAs (Roovers et al. 2006). 
Cbf5, which is typically involved in modifying several target sites in a guide RNA-
dependent manner, and can also modify archaeal tRNAs at position 55 with the help of 
two accessory proteins, but without a guide RNA (Gurha et al. 2007). Chapter 2 
describes the studies on this unexpected guide RNA-independent function of Cbf5 in 
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tRNA modification, with the aim to understand the contribution of the two accessory 
proteins, Nop10 and Gar1. To gain insight into this unexpected function of Cbf5, I have 
analyzed the steady-state kinetics of this reaction along with thermodynamic binding 
studies using purified components from an archaeal model, Pyrococcus furiosus. 
In addition to Cbf5, surprisingly, archaea evolved a novel  synthase, Pus10, with 
poor sequence similarity to the TruB family of synthases (TruB in bacteria, Pus4 and 
Cbf5 in eukaryotes) (Watanabe et al. 2000). In Chapter 3, as a first step towards 
understanding the newly discovered synthase Pus10, the biochemical analysis of wild-
type P. furiosus Pus10 and of several variants constructed using site-directed mutagenesis 
is described. The aim of this work is to determine if Pus10 evolved to be a more efficient 
enzyme than Cbf5, which would explain its in vivo role in 55 formation, and to learn 
how Pus10 functions in comparison to other known synthases.  
Together, it was the objective of these studies on Cbf5 and Pus10 (EC: 5.4.99.25) to 
provide comparative insight into incorporation by these two different enzymes. In 
Chapter 4, I have summarized the key findings from this thesis and the significance of 
this work, and discussed the potential future directions in the research of  modification 
that will eventually guide us towards a better understanding of this significant constituent 
of non-coding RNA.  
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Chapter 2: tRNA pseudouridylation by archaeal Cbf5 and the contribution of 
Nop10 and Gar1  
Reprinted from  
Archaeal proteins Nop10 and Gar1 increase the catalytic activity of Cbf5 in 
pseudouridylating tRNA 
Rajashekhar Kamalampeta and Ute Kothe 
Scientific Reports 2012; 2: 663 
DOI: 10.1038/srep00663 (2012) 
Copyright © 2012, Nature Publishing Group 
 
Contributions: 
UK designed the research, RK carried out all experiments, and UK wrote the manuscript. 
All authors reviewed the manuscript. 
Changes incorporated: 
An experiment performed to determine the optimal reaction conditions required for the 
pseudouridylation has been added, and some wording has been changed to maintain 
consistency with the other chapters. 
2.1 Introduction 
 synthases are found in all domains of life as they catalyze the formation of the most 
abundant RNA modification, the site-specific conversion of uridines to s. Based on 
their structure and sequence similarities,  synthases are classified into six families 
named by their bacterial representatives, TruA, TruB, TruD, RsuA and RluA (Hamma 
and Ferré-D'Amaré 2006) as well as the unrelated  synthase Pus10 found in archaea and 
some eukaryotes (Watanabe and Gray 2000). The diversity of  synthases allows them to 
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site-specifically target cellular RNAs such as ribosomal RNA, tRNA as well as small 
nuclear and small nucleolar RNA in eukaryotes. Typically, stand-alone  synthases 
functioning as a single protein recognize one or a small number of related substrate 
RNAs based on structure and/or sequence (Hamma and Ferré-D'Amaré 2006). In 
addition, archaea and eukaryotes harbor H/ACA small ribonucleoproteins comprised of 
the  synthase Cbf5 (dyskerin in humans), the accessory proteins Nop10, Gar1 and 
archaeal L7Ae or eukaryotic Nhp2 as well as an H/ACA guide RNA (Gannot et al. 1997; 
Ni et al. 1997). Here, the different H/ACA guide RNAs are responsible for recruiting the 
target RNAs through specific base-pairing interactions while Cbf5 remains the catalytic 
component of the complex (Lafontaine et al. 1998). However, the roles of the accessory 
proteins Nop10, Gar1 and L7Ae have not yet been fully established. 
Compared to uridines, s are characterized by a C-C glycosidic bond and extra second 
imino group in the base which can participate in additional hydrogen bonds. Presumably, 
these types of additional interactions confer increased stability to RNA containing s 
(Charette and Gray 2000). Furthermore, s near the active centers of the spliceosome and 
the ribosome have been implicated in the function of these molecular machines (Yang et 
al. 2005; Liang et al. 2007). While the exact details of the catalytic mechanism are still 
under investigation, it is very likely that all  synthases employ the same mechanism for 
pseudouridylation (McDonald et al. 2011) since all  synthases share a structurally very 
similar catalytic domain including a strictly conserved aspartate residue which may form 
a covalent bond to the ribose (Miracco and Mueller 2011). In addition, the active sites of 
 synthases are composed of a positively charged residue that interacts with the catalytic 
aspartate, and an aromatic residue that forms stacking interactions with the uracil ring 
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(Hamma and Ferré-D'Amaré 2006). In agreement with the suggested common catalytic 
mechanism, our lab has recently shown that three families of bacterial  synthases 
(TruA, TruB, and RluA) are characterized by a uniformly slow catalytic step (Wright et 
al. 2011). 
Cbf5 is the most complex  synthase as it is acting in conjunction with a guide RNA 
and proteins Nop10, Gar1, and archaeal L7Ae. The structure of the Pyrococcus furiosus 
H/ACA small ribonucleoprotein in the presence and absence of substrate RNA provided 
insight into the molecular architecture of the complex and suggested possible functions 
for its components (Li and Ye 2006; Duan et al. 2009). As mentioned, Cbf5 is the 
catalytic unit and interacts extensively with the guide RNA. Nop10 binds to Cbf5 close to 
the active site and has been proposed to stabilize it (Hamma et al. 2005), but it also forms 
some contacts to the guide RNA. Without Nop10, the H/ACA small ribonucleoprotein is 
inactive in modifying target RNA (Baker et al. 2005; Charpentier et al. 2005). Gar1 is the 
only protein not directly interacting with RNA; instead it can bind to the thumb loop of 
Cbf5, stabilizing it in an open conformation. Omission of Gar1 limits the guide RNA-
dependent pseudouridylation activity of H/ACA small ribonucleoproteins to a single 
round (Duan et al. 2009), presumably because product release is impaired when Gar1 is 
not inducing an open conformation of the thumb loop. Lastly, L7Ae binds to the kink-
turn motif in archaeal H/ACA guide RNA thereby helping to position the guide RNA and 
the substrate RNA within the complex (Liang et al. 2007). Interestingly, archaeal Cbf5 is 
also able to act in a guide RNA-independent manner as it can on its own introduce s at 
position 55 in the T arm of tRNAs like its bacterial homologue TruB (Roovers et al. 
2006). This activity is greatly enhanced by the addition of Nop10 and Gar1 (Gurha et al. 
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2007; Muller et al. 2007). The significance of this guide-independent activity of Cbf5 is 
not clear as it has been demonstrated that tRNAs are pseudouridylated in vivo by another 
archaeal enzyme, Pus10 (Blaby et al. 2011).  
Here, we ask the question why Cbf5 requires additional proteins, in particular Nop10 
and Gar1, for its optimal function. Answering this question is not possible by 
investigating the guide RNA-dependent reaction of the H/ACA small ribonucleoprotein 
complex, as it loses its complete guide-dependent activity without Nop10. Therefore, we 
dissected the role of Nop10 and Gar1 for the guide-independent tRNA modification by 
Cbf5. Our results clearly show that Nop10 and Gar1 not only increase Cbf5’s affinity to 
tRNA, but that they also enhance its catalytic activity.  
2.2 Methods 
2.2.1 Buffers and reagents 
Reaction buffer: 20 mM HEPES-KOH pH 7.0, 1.5 mM MgCl2, 150 mM KCl, 0.1 mM 
EDTA unless otherwise stated. Nucleotide triphosphates and guanine monophosphate for 
in vitro transcription, and inorganic pyrophosphatase were from Sigma; all other enzymes 
were from Fermentas. Chemicals were purchased from VWR, DNA oligos were obtained 
from IDT and [C5-
3
H] UTP (MT 553) was from Moravek. 
2.2.2 Molecular cloning and mutagenesis 
The genes encoding the proteins Cbf5, Nop10, and Gar1 were amplified from P. 
furiosus genomic DNA (ATCC, 43587D-5) using the following primers (restriction site 
in italics, Table 2.1) 
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Table 2.1. Primers used in amplifying P. furiosus Cbf5, Nop10, and Gar1 genes  
Primer Sequence (5’ to 3’) 
Cbf5 sense (BamHI) GGATCCGGCGAGAGACGAGGTAAGAAG 
Cbf5 antisense (SalI) GTCGACTTAGCTTCTATCTCTTTTTTCCC 
Nop10 sense (BglII) CCCGAGATCTCAGGTTTAGGATAAGGAAGTGTC 
Nop10 antisense (XhoI) CATTCTCGAGTCATTTTTCCTTCCTCCCTA 
Gar1 sense (his-tag, NheI) ATGGCTAGCGAAAAACAGGGTGAAAAAATG 
Gar1 sense (no his, NcoI) 
GCGCCATGGGCGAAAAACAGGGTGAAAAAATG 
Gar1 antisense (BamHI) TTCGGATCCTCATCTATTCAGCCTTTTCTTC 
 
Subsequently, the genes were inserted by blunt-end ligation into SmaI restricted 
pUC19 plasmid. Using restriction sites added through the primers, the genes were 
removed from the pUC19 plasmid and inserted into an expression vector which had been 
double-restricted with the appropriate enzymes and gel purified. This generated the 
following plasmids: pETDuet1-PfCbf5 (gene in multiple cloning site I including an N-
terminal hexahistidine tag), pETDuet1-PfNop10(nohis) (gene in multiple cloning site II 
without tag), pET28a-PfGar1 (including N-terminal hexahistidine tag), and pET28a-
PfGar1(nohis) (without tag used for purification in complex with Cbf5). To generate a 
catalytically inactive variant of Cbf5, QuikChange
TM
 mutagenesis was applied to change 
the catalytic aspartate to asparagine generating plasmid pETDuet1-PfCbf5D85N. All 
plasmids were verified by sequencing (Macrogen). 
 40 
2.2.3 Protein expression and purification 
For protein expression, plasmids were individually transformed into Rosetta 2(DE3) 
competent E. coli cells (EMD Bioscience) which provide the codons rarely used in E. coli 
and allow the induction of protein expression using IPTG. To express Cbf5 and Nop10, 
cells were grown at 37 °C in LB medium supplemented with 100 μg/mL ampicillin; for 
Gar1 and Pus10 expression, LB medium contained 50 μg/mL kanamycin. At an OD600 of 
~0.6, protein expression was induced by the addition of isopropyl β-D-1-
thiogalactopyranoside (IPTG) to a final concentration of 1 mM. In case of Gar1, cells 
were transferred to 30 °C prior to the induction. Cells were harvested three hours after 
induction by centrifugation at 5,000×g for 15 min, flash frozen and stored at -80 °C. 
Cbf5 and Gar1 were individually purified. For purification of Cbf5-Nop10 and Cbf5-
Nop10-Gar1 complexes, cells were mixed to allow formation of the protein complex 
during cell opening as in previous reports (Li and Ye 2006). In all cases, cells were 
resuspended in 5 mL/g buffer A1 for purification of Cbf5-Nop10 and Cbf5-Nop10-Gar1 
(25 mM sodium phosphate buffer (pH 7.6), 1M NaCl, 5% (v/v) glycerol, 30 mM 
imidazole and 0.1 mM phenylmethylsulfonyl fluoride (PMSF)) or buffer A2 for 
purification of Cbf5 and Gar1 alone (20 mM Tris-HCl pH 8.0, 300 mM KCl, 5 mM β-
mercaptoethanol, 5% (v/v) glycerol, 30 mM imidazole, 0.1 mM PMSF). Cells were lysed 
for 30 min on ice by adding 1 mg/mL lysozyme followed by addition of sodium 
deoxycholate (12.5 mg/g cells) and further incubation for 15 min on ice. The solution was 
sonicated five times for 1 min each (intensity level 6, duty cycle 60%, Branson Sonifier) 
and centrifuged for 45 min at 30,000×g, 4 °C. The lysate was then subjected to heat 
denaturation at 75 °C for 15 min followed by centrifugation for 30 min at 30,000×g,        
 41 
4 °C. For purification of Cbf5 alone, the heat denaturation step was omitted since we 
observed that this step rendered the protein inactive. The cleared lysate was loaded onto a 
5 mL Ni
2+
 Sepharose column (GE Healthcare) using a BioLogic LP chromatography 
system (BioRad) and washed extensively with buffer A1. The protein was subsequently 
eluted with a linear gradient (50 mL) to buffer B (same as A except for 500 mM 
imidazole and no PMSF). For purification of Cbf5, glycerol was immediately added to 
fractions to a final concentration of 20% (v/v). Peak fractions were analyzed by 15% 
SDS-PAGE, pooled and concentrated by ultrafiltration (Vivaspin MWCO 30,000 or 
10,000). Next, the protein was re-buffered either by ultrafiltration or by size exclusion 
chromatography using a Superdex 75 column (XK26/100 column, GE Healthcare) in 
buffer C (20 mM HEPES-KOH pH 7.5, 600 mM KCl, 1 mM EDTA, 20% (v/v) glycerol) 
at a flow rate of  1 mL/min (BioLogic DuoFlow chromatography system). Peak fractions 
were concentrated as before, flash frozen and stored in aliquots at -80 °C. 
Protein concentration was determined photometrically at 280 nm using a molar 
extinction coefficient of 46,410 M
-1
 cm
-1
 for Cbf5, 9,970 M
-1
 cm
-1
 for Nop10, and 11,460 
M
-1
 cm
-1
 for Gar1 (calculated using ProtParam (Gill and von Hippel 1989)), while 
concentration of Gar1 alone was determined at 210 nm using the extinction coefficient of 
20.5 ml mg
-1
 cm
-1
. The catalytically inactive mutant (D85N) of Cbf5 was purified either 
alone or in combination with Gar1, with Nop10, or both, essentially in the same way as 
explained above.  
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2.2.4 In vitro transcription and purification of tRNA and H/ACA guide RNA 
A plasmid, called pIDT-Smart-PftRNA
Asp
, encoding a T7 promoter followed by the 
gene for P. furiosus tRNA
Asp
 was purchased from Integrated DNA Technology. To 
generate H/ACA guide RNA, the sequence for P. furiosus H/ACA guide RNA Pf4 (5’-
AAUGCCCCUCCCCUCUCACACCCCCGUGAGAAGUGAGCGGGGGGCGGUCGG
GGAGGGGACAUCA-3’) (Klein et al. 2002) as well as a T7 promoter was assembled 
using overlapping oligos and cloned into a pUC19 vector. The template for the in vitro 
transcription of tRNA
Asp
 and Pf4 guide RNA was generated by PCR amplification from 
the corresponding plasmids using methylated reverse primers to precisely terminate 
transcription (Sherlin et al. 2001). The in vitro transcription was performed using the 
PCR template (10% (v/v)) in transcription buffer (40 mM Tris-HCl pH 7.5, 15 mM 
MgCl2, 2 mM spermidine, 10 mM NaCl, 10 mM DTT) with 3 mM each ATP, CTP and 
GTP, and 0.1 mM [C5-
3
H]UTP (23.9 Ci/mmole), 5 mM GMP, 0.01 U/μL inorganic 
pyrophosphatase, 0.3 μM T7 RNA polymerase and 0.12 U/μL RNase inhibitor at 30 °C 
for 4 h. Following the in vitro transcription, the template was digested with 2 U/mL 
DNaseI (Fermentas) for 1 h at 37 °C, and the RNA was purified with a Nucleobond 
AX100 column (Macherey-Nagel) using equilibration buffer R0 (100 mM Tris-acetate 
pH 6.3, 10 mM MgCl2, 15% (v/v) ethanol), washing buffer R1 (R0 with 300 mM KCl) 
and elution buffer R3 (R0 with 1150 mM KCl). The RNA was concentrated by 
isopropanol precipitation and dissolved in H2O. The tRNA concentration was determined 
photometrically at 260 nm using the extinction coefficient 5 × 10
5
 M
-1
 cm
-1
. The specific 
activity of the purified [
3
H]tRNA
Asp
 and [
3
H] guide RNA was determined by scintillation 
counting. 
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2.2.5 Nitrocellulose Filtration 
Prior to all experiments, [
3
H]tRNA
Asp
 and proteins were pre-incubated at 70 °C for 5 
min. To allow the tRNA to bind to protein, 5 or 10 nM [
3
H]tRNA
Asp
 was incubated with 
0 - 700 nM protein or protein complex in reaction buffer for 10 min at 70 °C. The 
complete 50 μL reaction mixture was then filtered through a nitrocellulose membrane 
followed by washing of the membrane with 1 mL cold reaction buffer. Membranes were 
dissolved for 30 min in 10 mL EcoLite scintillation cocktail (EcoLite (+), MP 
Biomedical), and the amount of tRNA bound to the protein retained on the membrane 
was determined by scintillation counting (Perkin-Elmer Tri-Carb 2800TR liquid 
scintillation analyzer). In order to obtain the dissociation constant (KD), the increase in 
the fraction of bound tRNA as a function of the protein concentration was analyzed by 
fitting to a quadratic equation (Wright et al. 2011) with [RNA] = 5 or 10 nM:  
Pbound = Amp x [(KD + [R] + [P]) / 2 – {(KD + [R] + [P]) 
2 
/ 4 – [P] x [R]} 0.5] 
Where Pbound is the percentage of bound tRNA, P and R are concentrations of protein and 
RNA, respectively, and Amp is the amplitude or final level of bound tRNA. Each 
titration was repeated at least three times; the KD and its standard deviation were 
determined for each titration by fitting in Graphpad Prism. The average KD including the 
largest standard deviation of individual titrations (which is larger than the standard 
deviation between the KDs of individual titrations) is reported in Table 2.2. 
2.2.6 Tritium Release Assay  
To identify the optimal conditions required for the in vitro pseudouridylation 
experiments, reactions were performed under multiple turnover conditions using 50 nM 
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Cbf5-Nop10 complex and 600 nM [
3
H]tRNA
Asp
. Beginning with the reaction buffer 
(section 2.2.1), the buffer was changed to determine the optimal concentrations of KCl, 
and MgCl2, and the optimal pH. Besides these conditions, the effect of 50 
o
C or 70
 o
C 
temperatures was assessed. For Michaelis-Menten titrations, different concentrations of 
[
3
H]tRNA
Asp
 (100 - 3000 nM) were incubated with 10 nM enzyme in reaction buffer plus 
0.2% (w/v) bovine serum albumin at 70 °C. For single-turnover experiments, 600 nM 
[
3
H]tRNA
Asp
 were incubated with 5 M enzyme at 70 °C. Samples were removed at the 
desired time points and added to 5 % (w/v) activated charcoal (Norit A, EMD, CX0655-
1) in 0.1 M HCl. Following centrifugation at 10,000×g for 2 min, the supernatant was 
added to 0.5 mL fresh 5 % (w/v) activated charcoal in 0.1 M HCl, mixed and centrifuged 
again. The supernatant was filtered through a glass wool plug in a 1 mL micropipet tip, 
and 0.8 mL of the resulting filtrate was then used for scintillation counting in 4 mL 
EcoLite scintillation cocktail. Each time course was repeated at least three times to 
determine the initial velocity, v0, by linear fitting. The dependence of the initial rates v0 
on the tRNA concentration was analyzed by fitting the data in GraphPad Prism using the 
Michaelis-Menten equation , and the catalytic constant, kcat, was 
determined by dividing vmax by the enzyme concentration (10 nM). The single-turnover 
experiments were analyzed by fitting the data to a single-exponential equation (Wright et 
al. 2011): 
Pseudouridine = Amp – Amp x exp (-k x t) 
Where Amp represents the amplitude and kΨ is the single-turnover rate constant of  
formation. 
 
])[/(][max0 SKSvv M 
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2.3 Results 
2.3.1 Optimal conditions required for pseudouridylation reactions  
In order to understand the contribution of proteins Nop10 and Gar1 on the 
pseudouridylation activity of Cbf5, a highly-purified Pyrococcus furiosus model system 
was used, similarly to previous studies (Baker et al. 2005; Charpentier et al. 2005; Li and 
Ye 2006). Each protein was individually expressed in Escherichia coli, and cells 
expressing the respective proteins were combined during cell opening to allow for 
formation of protein complexes. Subsequently, the individual proteins (Cbf5, Gar1) or 
protein complexes (Cbf5-Nop10, Cbf5-Nop10-Gar1) were purified by affinity and size-
exclusion chromatography utilizing the hexa-histidine tag engineered onto the N-
terminus of Cbf5 or Gar1. This purification strategy is essentially identical to previously 
published methods (Li and Ye 2006). All proteins were more than 95% pure as judged by 
SDS-PAGE. To study Cbf5’s activity in modifying archaeal tRNA, P. furiosus tRNAAsp, 
a substrate of Cbf5 (Roovers et al. 2006), was generated by in vitro transcription using 
[C5-
3
H]UTP and subsequently purified by anion exchange chromatography.  
Diverse buffer conditions have been used in pseudouridylation assays with Cbf5 
(Baker et al. 2005; Charpentier et al. 2005; Roovers et al. 2006; Gurha et al. 2007). By 
identifying the common buffer components used in these studies (HEPES, KCl, MgCl2, 
and EDTA) a systematic characterization was performed to determine the optimal 
concentrations of the selected buffer components required for  formation by Cbf5 in in 
vitro reactions. The extent of pseudouridylation was determined using a well-established 
tritium release assay detecting liberation of tritium from the C5 of the uracil base upon 
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formation of the new C-C glycosidic bond (Cortese et al. 1974). Multiple turnover 
experiments using lower enzyme (50 nM Cbf5-Nop10) than substrate concentrations (600 
nM [
3
H]tRNA) were performed in the reaction buffer , while changing the concentration 
of a single component at a time. Under all conditions, the time courses displayed a 
gradual increase in  formation over time (Figure 2.1). Initial velocities (v0) were 
determined from linear fits of the time courses in order to compare the effect of the varied 
component on the reaction rate. The wide range of KCl concentrations (0 mM - 1000 
mM) tested in these reactions revealed that Cbf5-Nop10 can introduce  into tRNA even 
in the absence of KCl. The rate of reaction increases with addition of KCl up to a 
concentration at 150 mM, reaching about 1 nM min
-1
 under our assays conditions (Figure 
2.1A). A further increase in the KCl concentration decreases the v0 with no  formation 
observed at 600 mM or higher concentrations of KCl. Based on these observations, 150 
mM KCl has been determined to be the optimal concentration for  formation by Cbf5-
Nop10. Next, a titration with MgCl2 showed only small amounts of  accumulation when 
no MgCl2 was used, while an increase in MgCl2 concentration also increases the v0 
values, which stay relatively constant between 1.5 mM to 10 mM MgCl2 (Figure 2.1B).  
Subsequently, experiments performed at different pH values (6 - 8) indicated that a 
neutral pH is optimal for these reactions with lower v0 values recorded upon decreasing or 
increasing the pH (Figure 2.1C). Further, tritium release experiments were carried out at 
50 
o
C and 70 
o
C to compare the effect of temperature on  formation. At 50 oC, the 
reaction progresses very slowly, resulting in less than 30% modification in 2 hours 
(Figure 2.1 A-C), when compared to the reaction at 70 
o
C that reached the same extent of 
 formation in less than 10 minutes (Figure 2.1 D).  
 47 
 
Figure 2.1. Optimization of buffer conditions for  formation using the Cbf5-Nop10 
complex.  
Tritium release assays were performed with 600 nM [
3
H]tRNA and 50 nM Cbf5-Nop10 
in the reaction buffer containing 20 mM HEPES (pH 7.0), 1.5 mM MgCl2, 150 mM KCl 
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and 0.1 mM EDTA at 50 ºC, unless otherwise specified.  formation at different reaction 
conditions was studied. A) KCl titration: 0 mM (filled circles), 50 mM (open circles), 150 
mM (filled squares), 250 mM (open squares), 400 mM (filled diamonds), 600 mM (open 
diamonds), 1000 mM (open triangles). B) MgCl2 titration: 0 mM (open squares), 1.5 mM 
(filled squares), 3 mM (filled circles), 5 mM (open circles), 10 mM (open diamonds). C) 
pH titration: 6.0 (filled circles), 6.5 (open circles), 7.0 (filled squares), 7.5 (open squares), 
8.0 (filled diamonds). D)  formation compared at different reaction temperatures: 50 ºC 
(circles) and 70 ºC (squares). Left side panels in the figure show the time courses and the 
right side panels show the reaction rates determined by fitting the time course to a linear 
equation. Smooth curves in left panel of figure D were obtained by fitting the time 
courses to a hyperbolic function. 
 
This corresponds to a significant enhancement in v0 (over twenty-fold) for increasing the 
temperature by 20 ºC. In accordance with our findings, 70 ºC has previously been shown 
to be the optimal temperature for P. furiosus Cbf5 (Roovers et al. 2006). In summary, 
these experiments identified the optimal conditions required for the in vitro 
pseudouridylation reactions by Cbf5 to be 150 mM KCl, pH 7, 1.5 to 10 mM MgCl2 and 
70 ºC. 
2.3.2 Multiple-turnover catalysis of tRNA modification by Cbf5 in absence and 
presence of Nop10 and Gar1 
To verify the activity of the in vitro reconstituted complexes, time courses of  
formation were recorded at 70°C, and under multiple turnover conditions (Figure 2.2). 
No tritium was released from the tRNA under these conditions in the absence of proteins. 
Notably, more than 80%  formation was observed after 60 min for the Cbf5-Nop10-
Gar1 complex as well as the Cbf5-Gar1 complex while the Cbf5-Nop10 complex yielded 
60%  formation in 60 min. Interestingly, Cbf5 alone only reached about 20% 
pseudouridylation after 60 min of incubation. This might be attributed to the general 
tendency of free Cbf5 to precipitate as observed during purification. It is difficult to 
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visualize the precipitation in the smaller volumes used in the reaction, but it is likely that 
the unstable nature of Cbf5 on its own may explain its inability to complete the reaction 
under in vitro conditions, although other reasons cannot be excluded. In general, our 
findings are consistent with previous studies which showed an increasing activity of Cbf5 
upon addition of Nop10 alone, Gar1 alone, or both Nop10 and Gar1, the latter Cbf5-
Nop10-Gar1 complex representing the most active complex (Roovers et al. 2006; Gurha 
et al. 2007; Muller et al. 2007). However all these studies were conducted under single-
turnover conditions using a large excess of enzyme over substrate. Therefore, our 
findings demonstrate for the first time that Cbf5 and its complexes with Nop10 and Gar1 
are able to catalyze tRNA modification in a multiple-turnover fashion.  
 
Figure 2.2. Time courses of  formation by Cbf5 alone and in the presence of Nop10 
and Gar1.  
1000 nM [
3
H]tRNA was incubated at 70 °C with 10 nM Cbf5-Nop10-Gar1 (filled 
circles), Cbf5-Gar1 (filled triangles), Cbf5-Nop10 (filled squares) or Cbf5 alone (open 
circles). As a control, 1000 nM [
3
H]tRNA was incubated in reaction buffer alone (open 
squares). The extent of  formation was quantified using the tritium release assay. 
 
They furthermore reveal that all of the analyzed complexes are capable of efficient 
product release in contrast to the guide RNA-dependent function of Cbf5 where the 
reaction is limited to a single round of catalysis when Gar1 is absent, presumably since 
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the product RNA cannot dissociate from the H/ACA small ribonucleoprotein (Duan et al. 
2009). In summary, we are using a highly-active, purified reconstituted in vitro system 
capable of multiple-turnover catalysis for studying pseudouridylation by Cbf5 in the 
presence and absence of Nop10 and Gar1. 
2.3.3 Steady-state kinetic analysis of tRNA modification by Cbf5 
In order to identify the role of Nop10 and Gar1 for tRNA modification by Cbf5, we 
have conducted steady-state kinetic experiments utilizing the fully active Cbf5-Nop10-
Gar1 complex as well as complexes lacking either Nop10 or Gar1. We did not analyze 
the Cbf5 enzyme alone due to its limited activity (Figure 2.2). Based on these 
experiments we have determined the catalytic constants (kcat) as well as the Michaelis 
constants (KM), which respectively provide insights into catalysis and interaction with the 
substrate RNA. Based on the initial, linear phase of product formation using 10 nM 
enzyme, v0 of the reaction could be determined by linear fitting (Figure 2.3A). The 
respective experiments were conducted at different tRNA concentrations ranging from 
150 to 3000 nM to determine the dependence of the initial velocity on the substrate 
concentration (Figure 2.3B-D). Fitting to a Michaelis-Menten equation provided the 
steady-state kinetic parameters kcat and KM summarized in Table 2.2. Interestingly, all 
three analyzed complexes exhibited very similar behavior at low tRNA concentrations (< 
300 nM tRNA). However, at higher tRNA concentration, the initial velocity of the Cbf5-
Nop10 as well as the Cbf5-Gar1 catalyzed reaction did increase only very slightly (Figure 
2.3B and C). In contrast, the Cbf5-Nop10-Gar1 complex showed a strong increase in 
initial velocity with higher substrate tRNA concentrations up to a velocity of 180 nM 
min
-1
 at 3000 nM tRNA without reaching saturation (Figure 2.3D). Thus, both Nop10 and 
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Gar1 contribute significantly to Cbf5’s activity in particular at high substrate 
concentrations. This trend is confirmed by the quantitative analysis of the titrations, as 
the kcat of the Cbf5-Nop10-Gar1 complex is 0.7 s
-1
, more than three-fold higher than that 
of Cbf5-Gar1 (0.2 s
-1
) and about six-fold larger than the kcat of the Cbf5-Nop10 complex 
(0.11 s
-1
).  
 
Figure 2.3. Steady-state kinetic analysis of pseudouridylation by the Cbf5-Nop10-
Gar1 complex and subcomplexes thereof.  
A. Short time courses using 1000 nM [
3
H]tRNA and 10 nM enzyme to determine the 
initial velocity (v0) of  formation by linear fitting. Cbf5-Nop10-Gar1 (circles), Cbf5-
Gar1 (triangles), Cbf5-Nop10 (squares). Similar time courses were recorded at different 
tRNA concentrations, and the obtained initial velocities were plotted against the substrate 
concentration (B-D). Different complexes of Cbf5 were used as enzymes: Cbf5-Nop10 
(B), Cbf5-Gar1 (C), and Cbf5-Nop10-Gar1 (D). Fitting to the Michaelis-Menten equation 
(smooth lines) yielded values for kcat and KM (see Table 2.2). 
 
Interestingly, the effect of Nop10 and Gar1 on the Michaelis-Menten constant, KM, is 
different than on kcat. The KM for tRNA decreases from about 4000 nM for the Cbf5-
Nop10-Gar1 complex to 920 nM for Cbf5-Gar1 and 260 nM for Cbf5-Nop10. This is 
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surprising as at first view, this would suggest that the Cbf5-Nop10-Gar1 complex is less 
efficient in interacting with substrate tRNA than the partially assembled complexes. 
Table 2.2. Kinetic parameters for tRNA modification by different Cbf5 complexes
a
 
 KM, nM kcat, s
-1
 kΨ, s
-1
 
Cbf5-Nop10-Gar1 4000  ± 1700 0.7 ± 0.2 > 0.2 
Cbf5-Gar1 920 ± 240 0.20 ± 0.03 0.06 ± 0.02 
Cbf5-Nop10 260 ± 70 0.11 ± 0.01 0.07 ± 0.02 
Cbf5 n.d. n.d. 0.04 ± 0.01 
n.d. – not determined 
a 
Each value for KM, kcat and kΨ is reported together with the standard deviation obtained 
from data fitting as described in the Methods. 
 
2.3.4 Substrate binding by Cbf5 alone and in complex with Nop10 and/or Gar1 
In order to shed more light on the mechanism of substrate binding by Cbf5-Nop10-
Gar1 and subcomplexes thereof, nitrocellulose filtration assays were performed to 
determine the dissociation constants (KD) for tRNA
Asp
 binding. To prevent modification 
of the bound tRNA, we have constructed a catalytically inactive Cbf5 variant by mutating 
the catalytic aspartate 85 to asparagine (D85N). This renders the protein completely 
inactive in pseudouridylation (Zebarjadian et al. 1999) (data not shown), while retaining 
its RNA binding abilities (see below). Subsequent to a 10 minute incubation of 10 nM 
[
3
H]tRNA in the presence of excess protein, the reaction mixture was filtered through a 
nitrocellulose membrane that retains protein and protein-bound tRNA. After washing of 
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the membrane with reaction buffer, the amount of retained and therefore bound tRNA 
was determined by scintillation counting of the nitrocellulose filters. In order to assess the 
role of Nop10 and Gar1 for tRNA binding, we analyzed not only the Cbf5D85N-Nop10-
Gar1, the Cbf5D85N-Nop10 and the Cbf5D85N-Gar1 complex, but also Cbf5D85N and 
Gar1 alone as Gar1 has been shown to bind RNA (Bagni and Lapeyre 1998). For all 
proteins and protein complexes tested, about 80% of the tRNA was bound to protein at 
high protein concentrations (Figure 2.4). Gar1 bound tRNA comparatively weakly (KD of 
750 nM, Table 2.3), and Cbf5D85N alone bound tRNA with an intermediate affinity (KD 
= 235 nM). However, all other complexes of Cbf5D85N with Nop10 and/or Gar1 
displayed a high affinity for tRNA ranging from 45 – 80 nM (Table 2.3). In comparison 
to Cbf5D85N alone, these results clearly show that both Nop10 and Gar1 enhance Cbf5’s 
ability to bind tRNA to a similar extent. Furthermore, these experiments demonstrate that 
the complete Cbf5-Nop10-Gar1 complex is fully capable of tight binding to the substrate 
tRNA despite its high KM (Figure 2.3 and Table 2.2). 
The large difference between the KD and the KM can be explained with the high 
catalytic activity of the Cbf5-Nop10-Gar1 complex. For a relatively simple mechanism 
assuming single-step binding (k1, k-1) followed by catalysis (k2), Briggs-Haldane showed 
that the KM is (k-1 + k2) / k1 (Fersht 1998). Only if the catalytic rate constant (k2) is low 
compared to dissociation of substrate (k-1) is the KD (= k-1/k1) equal to the KM, (Fersht 
1998). This is not the case for most enzymes including Cbf5-Nop10-Gar1 where KM is 
influenced not only by the rate constants for substrate binding (k1, k-1), but also by the 
rate constant of catalysis (k2) or other subsequent steps. While the exact kinetic 
mechanism of Cbf5-Nop10-Gar1 in modifying tRNA is not known, our data are 
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consistent with the Briggs-Haldane description of KM. As the Cbf5-Nop10-Gar1 complex 
has a relatively high catalytic constant, kcat, which most likely reflects the rate constant of 
catalysis, k2, it is expected that KM increases with k2. In contrast, the catalytic constant, 
kcat, is rather low for the Cbf5-Nop10 complex, and hence its KM value is of a similar 
order of magnitude as the KD, i.e. the Cbf5-Nop10 complex might follow the Michaelis-
Menten mechanism. In conclusion, the high KM of the Cbf5-Nop10-Gar1 complex seems 
to be a result of its high kcat value, or in other words the high catalytic activity of the 
Cbf5-Nop10-Gar1 complex is achieved by “sacrificing” the KM value for tRNA. Notably, 
this property does not necessarily have to apply to the complete H/ACA small 
ribonucleoprotein as it employs a different mechanism for substrate RNA binding based 
on guide RNA. 
Table 2.3. Affinity of Cbf5 complexes to substrate and product tRNA
a
 
 KD, nM 
(substrate tRNA) 
KD, nM 
(product tRNA) 
Cbf5 235 ± 65 n.d. 
Cbf5-Nop10-Gar1 45 ± 20 27 ± 10 
Cbf5-Gar1 80 ± 25 105 ± 25 
Cbf5-Nop10 50 ± 15 60 ± 20 
Gar1 750 ± 300 n.d. 
n.d. – not determineda Each KD is the average of at least three different nitrocellulose 
filtration experiments titrating protein against tRNA. Each average KD value is reported 
together with the largest standard deviation from individual filtration experiments. 
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Figure 2.4. Substrate tRNA binding by Cbf5 in the presence and absence of Nop10 
and Gar1.  
To determine the affinity of Cbf5 and Cbf5 complexes for unmodified substrate tRNA, 
[
3
H]tRNA was incubated with increasing concentrations of the catalytically inactive Cbf5 
D85N variant and associated proteins. The percentage of bound tRNA was recorded by 
nitrocellulose filtration and scintillation counting. The experiment was carried out with 
Gar1 alone (A), Cbf5D85N alone (B), Cbf5D85N-Nop10 (C), Cbf5D85N-Gar1 (D), and 
Cbf5D85N-Nop10-Gar1 (E). Fitting to a quadratic function (Materials and Methods, 
smooth lines) provided the dissociation constant, KD, for the interaction of Cbf5 and its 
complexes with substrate tRNA (see Table 2.3). Here, individual titrations are shown, but 
each experiment was repeated at least three times to determine the dissociation constants, 
KD, reported in Table 2.3. 
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2.3.5 Single-turnover tRNA modification by Cbf5 and Cbf5 complexes 
Next, we asked whether Gar1 could influence the release of product tRNA as it has 
been implicated in product release during the guide-dependent activity of the H/ACA 
small ribonucleoprotein (Duan et al. 2009). For this purpose, pseudouridylation assays 
were conducted under single-turnover conditions, i.e. with an excess of enzyme (5 M) 
over [
3
H]tRNA (0.6 M). Under these conditions, the tritium release assays detect the 
appearance of the enzyme-product complex as the active site is accessible to water and 
the released tritium can easily escape the active site. Therefore, the measured rate 
constant is independent of product release in contrast to the kcat measured under multiple 
round conditions. If product release is rate-limiting under multiple turnover conditions, 
for example upon omission of Gar1, the kcat would be lower than the single-round rate 
constant of  formation (kΨ). It is therefore the aim of these single-round experiments to 
assess whether product release is limiting by comparing kΨ and kcat. For these 
experiments, very short time courses have to be measured as the reaction is expected to 
be rather fast. Usually we would achieve this by using the rapid-mixing quench flow 
apparatus; however, this is not feasible at 70 ºC. Therefore, the experiments were 
performed by hand allowing at least a rough estimation of single-round pseudouridylation 
rate constants (kΨ). Again, all Cbf5 complexes with Nop10 and/or Gar1 achieved 80% or 
more product formation in a short time (Figure 2.5). Interestingly, Cbf5 alone was able to 
form s with a rate of 0.04 s-1 under these conditions, but failed to convert more than 
30% of all tRNAs, which again might be explained by an instability of Cbf5 during the 
course of the experiment. As expected based on the kcat, the complete Cbf5-Nop10-Gar1 
complex had converted all substrate to product within the first 10 seconds, thus indicating 
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that the single-round rate constant is at least 0.2 s
-1
 or larger. Interestingly, upon omitting 
Gar1, the Cbf5-Nop10 complex displayed a single-round rate constant of 0.07 s
-1
 which 
is very similar to the kcat value of 0.11 s
-1
 for this complex given the precision of the 
measurements (Table 2.2). This clearly demonstrates that product release is fast for the 
Cbf5-Nop10 complex. Therefore, Gar1 is not involved in tRNA product release in 
contrast to its function in the guide-dependent reaction (Duan et al. 2009). For the Cbf5-
Gar1 complex, the single-round rate constant is 0.06 s
-1
 and therefore also in a 
comparable magnitude to the kcat (Table 2.2). This indicates that Nop10 is also not 
involved in product release. 
 
Figure 2.5. Effect of Nop10 and Gar1 on a single-round of  formation by Cbf5. 
0.6 M of [3H]tRNA was incubated with 5 M of Cbf5 and accessory proteins at 70°C, 
and  formation was determined using the tritium release assay. Under these conditions, 
each Cbf5 can only modify a single tRNA. The tRNA was reacted with Cbf5-Nop10-
Gar1 (filled circles), Cbf5-Gar1 (filled triangles), Cbf5-Nop10 (filled squares), or Cbf5 
alone (open circles). The time courses were fit to a single-exponential equation to 
estimate the single-turnover rate constant of  formation, kΨ (Table 2.2). 
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2.3.6 Interaction of Cbf5 complexes with modified product tRNA and H/ACA 
guide RNA 
Based on previous studies reporting that  synthases can bind modified product tRNA 
(Ramamurthy et al. 1999), we next examined whether this is also the case for Cbf5. To 
this end, the nitrocellulose filtration assays with [
3
H]tRNA were repeated in the presence 
of active, wild-type Cbf5 in complex with Nop10 and/or Gar1. As shown in the single-
turnover pseudouridylation assay (Figure 2.5), all uridines should be converted to s by 
the Cbf5-Nop10, Cbf5-Gar1 and Cbf5-Nop10-Gar1 complexes during the 10 minute 
incubation period at 70 ºC allowing the measurement of modified product tRNA binding. 
Interestingly, all Cbf5 complexes again displayed relatively tight tRNA binding reaching 
maximal binding at protein concentrations between 100 - 200 nM (Figure 2.6). Fitting of 
the data revealed the dissociation constants (KD) as summarized in Table 2.3. The 
comparison to the respective affinities for unmodified substrate tRNA reveals that Cbf5 
complexes with Nop10 and/or Gar1 bind with similar affinities to substrate and product 
tRNA. Notably, tight binding of the product tRNA does not exclude rapid product 
release; instead it is likely that product binding is a dynamic equilibrium with rapid 
dissociation and re-association of the tRNA. 
Lastly, we asked how the interaction of the Cbf5-Nop10-Gar1 complex with tRNA 
compares to its interaction with H/ACA guide RNA as it occurs in the archaeal cell. 
Therefore, [
3
H]-labeled H/ACA guide RNA Pf4 (Klein et al. 2002) was prepared and 
used in nitrocellulose filtration assays with Cbf5-Nop10-Gar1. The titration revealed that 
H/ACA guide RNA binds tightly to Cbf5-Nop10-Gar1 reaching the end level already at 
100 nM of protein. The dissociation constant for the interaction of Cbf5-Nop10-Gar1 
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with H/ACA guide RNA Pf4 is 21 ± 8 nM as determined in three independent 
experiments. Hence, Cbf5-Nop10-Gar1 binds guide RNA as tightly as tRNA (see Table 
2.3). 
 
Figure 2.6. Binding of modified product tRNA in comparison to H/ACA guide RNA 
by Cbf5 in presence and absence of Nop10 and Gar1.  
[
3
H]tRNA or [
3
H] H/ACA guide RNA was incubated at 70 °C for 10 minutes with 
increasing concentrations of wild-type, active Cbf5-Nop10-Gar1 as well as complexes 
missing Nop10 or Gar1 followed by nitrocellulose filtration and scintillation counting to 
determine the percentage of bound product tRNA. The tRNA experiment was performed 
with Cbf5-Nop10 (A), Cbf5-Gar1 (B), and Cbf5-Nop10-Gar1 (C). The H/ACA guide 
RNA was bound to Cbf5-Nop10-Gar1 (D). Smooth lines are the result of fitting to a 
quadratic function yielding the dissociation constants, KD, for product tRNA binding (see 
Table 2.3) and H/ACA guide RNA binding (21 ± 8 nM). Again individual, representative 
titrations are shown. 
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2.4 Discussion 
Here, we present the first quantitative analysis of guide-independent  formation by 
archaeal Cbf5 in the presence and absence of its accessory proteins Nop10 and Gar1. Our 
findings demonstrate that both Nop10 and Gar1 enhance Cbf5’s catalytic activity. 
Furthermore, they improve Cbf5’s interaction with its substrate tRNA. In contrast to the 
guide-dependent reaction, Gar1 does not affect product release by Cbf5. All Cbf5 
complexes are capable of tight binding to both the substrate and the product tRNA. These 
quantitative findings allow for the first time a detailed insight into the role of the 
accessory proteins Nop10 and Gar1. 
Our results unambiguously show that lack of either Nop10 or Gar1 from the full Cbf5-
Nop10-Gar1 complex reduces the catalytic constant, kcat, revealing a role of Nop10 and 
Gar1 in enhancing the catalytic ability of Cbf5. In general, the active site of  synthases 
contains three residues that have been implicated in catalysis: an aspartate that is essential 
for catalysis as well as a tyrosine (phenylalanine in TruD) and an arginine or lysine 
interacting with the catalytic aspartate (Hamma and Ferré-D'Amaré 2006). Our findings 
raise the question of how Nop10 and Gar1 can influence the active site of Cbf5.  
The different crystal structures of Cbf5-Nop10-Gar1 support the hypothesis that 
Nop10 and Gar1 may influence all three active site residues of Cbf5 and may contribute 
to positioning of the substrate tRNA. As seen in the crystal structures of Cbf5-Nop10-
Gar1, Nop10 binds in the vicinity of Cbf5’s active site whereas Gar1 can interact with 
Cbf5’s thumb loop, but is not close to the active site of Cbf5 (Figure 2.7) (Li and Ye 
2006; Rashid et al. 2006). Based on these structural constraints, it is highly unlikely that 
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either Nop10 or Gar1 contribute a residue directly to the active site which is also in 
accordance with the observation that significant catalytic activity is retained upon loss of 
Nop10 or Gar1. Instead, we hypothesize that Nop10 and Gar1 are indirectly influencing 
Cbf5’s activity. For Nop10, it has already been proposed based on the crystal structures 
that it stabilizes the active site of Cbf5 (Hamma et al. 2005). Nop10’s linker region 
directly interacts through a so-called proline spine with the conserved motif I in Cbf5 
which is located next to the active site and contacts the catalytic aspartate residue 
(Hamma and Ferré-D'Amaré 2010). Additionally, the N-terminal domain, specifically the 
conserved tyrosine 14 of Nop10 (P. furiosus numbering as in Duan et al. 2009), contacts 
the conserved valine 114 in 4 of Cbf5 which is next to the conserved tyrosine 113 
residue that has been implicated in catalysis (Hamma et al. 2005). Hence the effect of 
Nop10 on Cbf5’s catalytic ability might result from a stabilization of motif I in Cbf5 and 
4 thereby correctly positioning the active site residues aspartate 85 and tyrosine 113 
(Figure 2.7). Gar1 contacts the C-terminus of Cbf5’s helix 5 which contains arginine 184 
at its N-terminus, the third of the active site residues. Additionally, Gar1 can interact with 
Cbf5’s thumb loop in the so-called open conformation (Li and Ye 2006) and maintains 
interactions with Cbf5’s strand 7 preceding the thumb loop in the closed conformation 
(Duan et al. 2009). As the thumb loop interacts with substrate RNA in presence of guide 
RNA (Li and Ye 2006), it can be envisioned that Gar1’s interaction with 7 could also 
help to correctly position tRNA in Cbf5’s active site (Figure 2.7). Thus, Gar1 could 
influence the active site geometry of Cbf5 by correctly positioning helix 5 of Cbf5 and 
thereby the catalytic arginine, and it could indirectly enhance catalysis by substrate 
positioning with the help of the thumb loop.  
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Figure 2.7. Contacts between Nop10 and Gar1 and the active site of Cbf5. 
The upper panel shows the structure of the complete H/ACA small ribonucleoprotein 
with guide RNA and L7Ae depicted in grey (PDB ID: 2HVY (Li and Ye 2006)); the 
active site of Cbf5 as shown below is indicated by the boxed area. The active site 
residues of Cbf5 (Asp85, Tyr113, and Arg184) are shown in red. Nop10 is depicted in 
cyan and Gar1 in purple. Residues of Nop10 indicated in pink are in contact with Cbf5 
residues shown in green that are in the direct neighborhood of the active site residues 
Asp85 and Tyr113. Gar1 contacts helix 5 of Cbf5 (yellow) that contains the active site 
Arg184 at its N-terminus; furthermore Gar1 interacts with Cbf5’s 7 strand preceding the 
thumb loop (orange) which can interact with the substrate RNA. These contacts can 
potentially contribute to the stabilization of Cbf5’s active site by Nop10 and Gar1. The 
figure was prepared using PyMol (DeLano Scientific LLC, 2006). 
 
The finding that Nop10 and Gar1 enhance Cbf5’s catalytic activity during tRNA 
modification likely also applies to the guide-dependent pseudouridylation by Cbf5. Both 
the guide-dependent and the guide-independent reaction analyzed here are taking place in 
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the same active site of Cbf5; and Nop10 and Gar1 interact in the same way with Cbf5 in 
the absence and presence of guide RNA as is evident upon comparing the isolated Cbf5-
Nop10-Gar1 structure and the full H/ACA small ribonucleoprotein (Li and Ye 2006; 
Rashid et al. 2006), Therefore, we hypothesize that the roles of Nop10 and Gar1 in 
stabilizing Cbf5’s active site during catalysis also hold true for the guide-dependent 
reaction. Notably, it would not have been possible to identify these functions of Nop10 
and Gar1 by studying the guide-dependent reaction as lack of Nop10 completely inhibits 
 formation (Baker et al. 2005; Charpentier et al. 2005) and lack of Gar1 limits the 
reaction to a single round (Duan et al. 2009). Our findings do not exclude other roles of 
Nop10 and Gar1 in the guide-dependent reaction in particular for substrate RNA binding 
and product release which might be substantially different from Cbf5’s interactions with 
tRNA. 
Notably, Cbf5-Nop10-Gar1 displays a similar catalytic constant of about 0.7 s
-1
 to the 
rate constants of pseudouridylation by bacterial  synthases TruB, TruA and RluA (0.35 
to 0.7 s
-1
) (Wright et al. 2011). It has been previously discussed that this relatively low 
catalytic rate constant will most likely apply to all bacterial stand-alone  synthases. The 
findings for Cbf5-Nop10-Gar1 now suggest that uniform slow catalysis is a general 
feature of  synthases that holds true also for complex  synthases such as Cbf5. 
Possibly, such a slow rate of catalysis is a result of the chemical mechanism required for 
 formation. Pseudouridylation consists of at least cleavage of the glycosidic bond, 
rotation of the uracil base and formation of the new C-C glycosidic bond, and this 
reaction is presumably catalyzed by the same mechanism in all  synthases sharing a 
conserved catalytic domain and conserved active site residues (Hamma and Ferré-
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D'Amaré 2006). As this is a chemically complex reaction, it might not be possible to 
enhance  formation to more than 0.35 – 0.7 s-1. 
The nitrocellulose filtration assays reveal high-affinity equilibrium binding constants 
(KD) in the low nanomolar range for both substrate and product tRNA and all Cbf5 
complexes. Both Nop10 and Gar1 are able to enhance Cbf5’s ability to bind tRNA as the 
KDs for the protein complexes are between 27 and 105 nM while Cbf5 alone binds tRNA 
with a KD of 235 nM (Table 2.3). Again, this improved tRNA binding might be a result of 
the overall stabilization of Cbf5 by Nop10 and Gar1. Furthermore, Nop10 could directly 
contribute to tRNA binding as it also forms contacts to the guide RNA in the H/ACA 
small ribonucleoprotein (Li and Ye 2006). Gar1 does not contact the guide RNA and 
might not be directly involved in tRNA binding; accordingly, at least for product binding, 
Gar1’s effect on the affinity of Cbf5 for tRNA seems to be smaller than the effect of 
Nop10 (Table 2.3). Overall, our findings suggest that, although tRNA is not the in vivo 
substrate of Cbf5, Cbf5 has retained the ability to interact with tRNA similarly as its 
bacterial homologue TruB. Interestingly, Cbf5 alone and its complexes display an even 
higher affinity for tRNA than TruB (Ramamurthy et al. 1999; Wright et al. 2011). Based 
on a structural comparison of Cbf5 with TruB and its interaction with tRNA (Hoang and 
Ferré-D'Amaré 2001; Li and Ye 2006), it is likely that the tRNA binding site on Cbf5 
overlaps with the guide RNA binding site. As this guide RNA binding site of Cbf5 is 
rather large, the high tRNA affinity of Cbf5 might reflect the ability of Cbf5 to tightly 
bind H/ACA guide RNA which has an equally high affinity (Figure 2.6D). Furthermore, 
it is not surprising that binding of modified product tRNA to the Cbf5 complex is very 
similar to binding of unmodified substrate tRNA as the introduction of  represents a 
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relatively minor change to the overall tRNA structure. Similarly, binding of product 
tRNA has previously been observed for TruB (Ramamurthy et al. 1999).  
In contrast to Gar1’s function during the guide-dependent reaction, Gar1 is not 
involved in product release from Cbf5 for the guide-independent modification of tRNA 
(Duan et al. 2009). Our data clearly show that multiple rounds of catalysis can occur 
rapidly in the absence of Gar1, i.e. for the Cbf5-Nop10 complex. Also, the single-round 
rate constant of catalysis, kΨ, is similar to the multiple round catalytic constant, kcat, for 
the Cbf5-Nop10 complex indicating that product release is not rate-limiting. In fact, 
product release is also rapid for Cbf5-Nop10-Gar1 and Cbf5-Nop10, i.e. rapid tRNA 
release seems to be a general feature of the guide-independent reaction. This differential 
function of Gar1 for product release in the guide-dependent and -independent RNA 
modification can best be explained by a different mode of substrate binding. In the 
presence of a guide RNA, the substrate RNA is held in place through several base-pairs. 
In contrast, the tRNA directly interacts with the proteins, predominantly Cbf5 and maybe 
Nop10, and these contacts might be easier to break during release of the product tRNA. 
In summary, the first quantitative analysis of  formation by Cbf5-Nop10-Gar1 
reported here reveals that both Nop10 and Gar1 can stabilize the active site of Cbf5 
thereby enhancing its catalytic activity. We hypothesize that this is a general feature of 
Nop10 and Gar1 which could also indirectly contribute to catalysis during the guide-
dependent reaction. Furthermore, we demonstrate for the first time that Cbf5-Nop10-
Gar1 complexes have very high affinities for tRNA in the low nanomolar range, but are 
capable of rapidly releasing modified product tRNA. As Cbf5-Nop10-Gar1 displays an 
equally high affinity to H/ACA guide RNA as to tRNA, we suggest that Cbf5-Nop10-
 66 
Gar1 might be mostly found bound to guide RNA in the archaeal cell and might therefore 
not be available for modifying tRNA which is instead catalyzed by Pus10 in vivo. This 
quantitative characterization of the complex archaeal  synthase Cbf5 in tRNA 
modification paves the way for further studies into the mechanism of guide-RNA 
dependent  formation by the H/ACA small ribonucleoprotein complex. 
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Chapter 3: Structure-guided functional analysis of archaeal Pus10 in pseudouridine 
55 formation in tRNA 
3.1 Introduction 
tRNAs in all domains of life contain  at position 55. 55 in tRNA appears to be 
highly conserved due to its structural role in allowing the tertiary base-pairing with the 
conserved G18, which in turn facilitates the stacking of neighboring m
5
U54 and 
conserved purine at position 57 (Romby et al. 1987). In addition to this well established 
structural role, the Björk group has demonstrated that preventing the modification of 55 
reduces expression of several virulence genes in the human pathogen, Shigella flexneri 
(Urbonavicius et al. 2002). Their work also shows reduced growth rates and defects in 
translation of certain codons in E. coli cells when 55 was excluded from tRNA in 
combination with two other modifications (Gm18, m
5
U54). In bacteria, TruB is 
responsible for converting uridine to  at this position (Nurse et al. 1995), while Pus4, a 
TruB homolog, performs this modification in eukaryotes (Becker et al. 1997). 
Conversely, Cbf5, another homolog of TruB found in archaea and eukaryotes, is shown 
to be involved in modifying rRNA as part of the H/ACA small ribonucleoprotein 
complex, which contains three accessory proteins (Nop10, Gar1, and L7Ae) and a guide 
RNA (Baker et al. 2005; Charpentier et al. 2005). Notably, archaeal Cbf5 also has the 
ability to perform 55 modification in tRNA under in vitro conditions (Roovers et al. 
2006). This function of tRNA modification by archaeal Cbf5 is guide-RNA-independent, 
but requires Nop10 and Gar1 for optimal activity (Roovers et al. 2006; Gurha et al. 
2007).  
 68 
Besides Cbf5, another protein called PsuX (later named Pus10) was identified in 
archaeal organisms while searching for Cbf5 homologs (Watanabe and Gray 2000). This 
protein was also demonstrated to modify 55 in archaeal tRNAs (Roovers et al. 2006). 
Pus10 is reported to have the ability to introduce 54 as well in tRNA, although with 
varied efficiencies and in a salt-dependent manner (Gurha and Gupta 2008). Interestingly, 
Pus10 homologs are also found in a few eukaryotes such as Caenorhabditis elegans, 
Drosophila Melanogaster, mouse, plants and humans, but not in yeast (Watanabe and 
Gray 2000; McCleverty et al. 2007). It might be that the Pus10 gene has been acquired in 
these eukaryotes through horizontal gene transfer. No Pus10-related sequences are 
observed in bacteria (Watanabe and Gray 2000). The discovery of Pus10 revealed a 
redundant system in archaea for tRNA modification at position 55. It was found that 
Pus10 can efficiently complement for truB in the null strain of E. coli supporting a likely 
role of Pus10 in 55 formation in vivo (Roovers et al. 2006). To provide direct evidence 
for the involvement of Pus10 in 55 formation in the cell, Dr. Gupta’s group in 
collaboration with others conducted in vivo studies using a Haloferax volcanii Cbf5-
deletion strain (Blaby et al. 2011). Based on the observation of 55 modification in the 
Cbf5 deletion strain, they concluded that it is Pus10, not Cbf5 that introduces 55 in 
archaea. However, it is not clear what prevents Cbf5 from performing this modification 
in the cell. It is important to note that in this work, the authors showed that Pus10 is 
essential for this halophile, as the strain with a chromosomal deletion of Pus10 could only 
grow in the presence of plasmid-encoded Pus10 expressed under the regulation of an 
inducible promoter.    
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Due to the lack of sequence similarity to other known  synthases, Pus10 was placed 
in its own new family i.e. the 6
th
 family of  synthases (Watanabe and Gray 2000). The 
crystal structure of human Pus10 was solved in the absence of the substrate (McCleverty 
et al. 2007). Pus10 is a crescent-shaped molecule with a C-terminal catalytic domain and 
an accessory domain at its N-terminus (Figure 3.1). Many  synthases contain an 
accessory domain that is implicated in binding the substrate RNA. It was proposed that 
the accessory domain in archaeal Pus10, the so-called THUMP domain (named after its 
existence in Thiouridine synthases, Methylases, and Pseudouridine synthases), may also 
play a similar role in tRNA binding (Aravind and Koonin 2001). The crystal structure 
revealed that the N-terminal domain of Pus10 is composed of nine -helices arranged in 
two bundles of three helices each, a mixed three-stranded -sheet packing against two of 
the remaining -helices, and several loops connecting these secondary structures (Figure 
3.1). Although this domain exhibits high sequence variation, there are two conserved 
features identified. First, this domain was observed to bind a zinc ion through tetrahedral 
coordination by four highly conserved cysteines, at positions 21, 24, 109, and 112 in 
human Pus10 (corresponding to 16, 19, 57, and 60 in P. furiosus). This motif is 
conserved in all Pus10 sequences, displaying a CX2CX84CX2C sequence in human Pus10, 
with standard spacing within each cysteine pair, while the spacing between the pairs 
appears to be variable (e.g. in P. furiosus it is CX2CX37CX2C). Pus1, another  synthase 
from yeast, was also shown to contain a zinc-binding motif, in addition to archaeal 
Nop10, an accessory protein found in the H/ACA sRNP complex. Second, the N-terminal 
domain of Pus10 possesses several conserved positively charged residues forming a basic 
cleft that is placed opposite to the putative active site in the C-terminal domain.  It was 
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predicted that this conserved patch of basic residues may be involved in mediating the 
interaction with tRNA (McCleverty et al. 2007). Given the unique presence of the 
THUMP domain in Pus10 among all  synthases, it is not clear if this domain is involved 
in binding the tRNA. In particular the role of the conserved basic residues and the 
function of the zinc-binding motif are unknown. It is also not clear if this domain is 
essential for the function of Pus10.  
Despite poor sequence similarity of Pus10 to other  synthases, its catalytic domain 
displays all the conserved motifs found in  synthases, including conserved active site 
residues (McCleverty et al. 2007). The C-terminal domain displays an extended platform 
created by a set of antiparallel, one four-stranded and one five-stranded, -sheets 
connected through parallel strands, flanked by two -helices (Figure 3.1). Four more 
helices were also found packing against this platform. The crystal structure shows the 
active site located in a deep basic pocket lined by the conserved sequence motifs 
containing the catalytic aspartate (210, according to P. furiosus numbering), and a highly 
conserved arginine (208) from motif II, tyrosine (274) from motif IIa, a basic residue 
(348) from motif III, and a leucine (375) from motif IIIa (Figure A1). Like other  
synthases, Pus10 also contains two RNA-binding loops, called the forefinger loop and 
thumb loop. As in several  synthases, these loops are located adjacent to the active site 
of the enzyme and are involved in stabilizing the interaction of substrate with the enzyme 
(Hamma and Ferré-D'Amaré 2006). In P. furiosus, the thumb loop of Pus10 contains 
several conserved positively charged residues adding to the highly basic nature of the 
catalytic pocket. In contrast, the forefinger loop appears to have low sequence 
conservation (Figure A1) with only a single basic residue conserved in eukaryotic 
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sequences. Based on a model created by docking tRNA onto Pus10, it was proposed that 
the TC loop carrying the target uridine is placed into the basic cleft of the catalytic 
domain by accommodating the tRNA acceptor stem in another basic cleft between the C- 
and N-terminal domains, while the 3’ end is engaged by the positively charged amino 
acids in the THUMP domain (McCleverty et al. 2007). Except for the predictions made 
using this model, our knowledge on the interaction of tRNA with Pus10 is limited.  
 
Figure 3.1. Structure of human Pus10 showing the amino acid residues selected for 
the current study. 
Cartoon representation of human Pus10 (full-length Pus10 (top) (PDB ID: 2V9K), N-
terminal domain (left, in cyan), and C-terminal domain (right, in green)) showing the 
amino acid residues (in stick form) targeted for site-directed mutagenesis. Residues are 
labeled with single letter codes and numbered according to P. furiosus Pus10. The zinc 
ion and the catalytic aspartate are shown as red and blue spheres, respectively. The 
corresponding numbering of amino acid residues in human Pus10 is as follows, in 
parentheses: C16 (C21), C19 (C24), R22 (R27), R121 (R176), K125 (K183), F181 
(L314), R208 (R342), D210 (D344), P306 (P445), R308 (R447), R313 (R452), and R318 
(R457). The figure was prepared using PyMOL (DeLano Scientific LLC, 2006). 
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To gain insight into the function of Pus10 in pseudouridylation of tRNA, site-directed 
mutagenesis was performed to create Pus10 variants with selected single amino acid 
substitutions in the thumb loop and the THUMP domain, and to generate a variant with 
two point mutations to eliminate zinc binding. In addition, a deletion variant containing 
only the Pus10 C-terminal catalytic domain was designed. Using the Pus10 wild-type and 
the Pus10 variants, the first quantitative biochemical characterization was performed to 
assess the catalytic efficiency of Pus10, and to explore the role of the N-terminal 
THUMP domain and the contribution of the thumb loop to the catalytic activity of Pus10. 
Our results demonstrate that the THUMP domain plays an important role in Pus10 
interaction with tRNA, and that the thumb loop is critical for efficient catalysis by Pus10. 
These studies also show the essential catalytic role of arginine 208 and provide insight 
into the differences in efficiency of Pus10 compared to the Cbf5-Nop10-Gar1 complex in 
pseudouridylating tRNA.    
3.2 Materials and Methods 
3.2.1 Buffers and reagents 
Buffers and reagents are described in Chapter 2 unless otherwise specified.  
3.2.2 Molecular cloning and mutagenesis 
The open reading frame of Pus10 was amplified from P. furiosus genomic DNA 
(ATCC, 43587D-5) using the following primers (restriction sites are in italics):  
Pus10 sense (NheI) 5’-GCTAGCATACTTGAAAAAGCCAGAGAGATATTGGAG-
3’ 
Pus10 antisense (XhoI) 5’-CTCGAGTCAATTATCTCCCTCAACATCGTCC-3’ 
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The amplified Pus10 gene was blunt-end ligated into a SmaI restricted pUC19 plasmid to 
create pUC19-PfPus10. Subsequently, a double-digestion of pUC19-PfPus10 was 
performed using XhoI and NheI and the Pus10 gene fragment was purified by gel 
extraction. The resulting Pus10 gene was inserted into pET28a that was also double-
digested by the same set of restriction enzymes to create pET28a-PfPus10. This construct 
allowed the expression of Pus10 carrying an N-terminal hexahistidine tag.  
An N-terminal deletion mutant (Pus10 ∆N) was created in a PCR reaction using 
pET28a-PfPus10 and the primers given below by amplifying the entire plasmid excluding 
the N-terminal domain of Pus10 (1-159 residues):  
∆N sense   5’-pCCAATATATGTAGCTGGGAGGTATAGAAAGCTC-3’ 
∆N antisense   5’-GCTAGCCATATGGCTGCCGC-3’ 
Template DNA was removed by overnight DpnI digestion at 37 °C. Next, the linear 
product obtained in the PCR reaction was ligated by T4 DNA ligase to re-circularize the 
plasmid which was then transformed into high efficiency competent E. coli DH5 cells 
(New England Biolabs). Colonies were selected for resistance to kanamycin and screened 
by restriction analysis. Plasmids purified from the selected colonies were verified by 
sequencing (GENEWIZ). 
Selected point mutations were introduced into the Pus10 gene by QuikChange
TM
 site-
directed mutagenesis (Stratagene) employing the sense primers listed in Table 3.1. In 
addition to the point mutations, a double mutant was constructed, wherein two of the four 
conserved cysteine residues were mutated to alanine. Plasmids positive for the selected 
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point mutations were identified by restriction analysis utilizing either the restriction site 
that is removed or newly introduced by the primers and confirmed by sequencing.   
Table 3.1. Primers used for site-directed mutagenesis of Pus10 
Primer Sequence (5’ to 3’) 
C16/19A GGAGCATCAACTGGCCAACCACGCCTTGGGTAGGTTATTTGG 
R22A CCACTGCTTGGGTGCGTTATTTGGAAAGCTTGGGAAGGGAAC 
R121A GATTACAAAAGAGTTCAACGCGGAGCTCGGGAAAGTTATTGCAG 
K125A GAGTTCAACAGGGAGCTCGGGGCAGTTATTGCAGTTAGATATGG 
F181A CATTAGAGGAATTCCCCAAACTCCAGCCCCTGGGGCTAAGGAGAGC 
R208A CAAAGGAGCTGGGGCAGAAGACGTGGACGTTAGAATGC 
D210N GGAGCTGGGAGAGAAAACGTGGACGTTAGAATGCTG 
P306G CGGAAATTAAACAGAGAACCGGTAGGAGAGTACTCAATAGTAGAGC 
R308A 
GAACCCCCAGGGCAGTGCTCAATAGTAGAGCAGATCTAGTTAGAGT
TAG 
R313A 
CCAGGAGAGTGCTCAATAGTGCAGCAGATCTAGTTAGAGTTAGAAA
GG 
R318A 
AGGAGAGTGCTCAATAGTAGAGCAGATCTAGTTGCAGTTAGAAAGG
TTTACG 
Sequences of sense primers are given; antisense primers are exact complements of sense 
primers. The mutated nucleotides are highlighted in bold and newly introduced restriction 
sites in italics. 
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3.2.3 Protein expression and purification 
Protein expression and purification of Pus10 wild-type and those carrying the desired 
mutations were performed essentially as described for Cbf5-Nop10 in Chapter 2. In brief, 
either wild-type or mutant plasmid was transformed into Rosetta 2(DE3) competent E. 
coli cells; cells were grown at 37 °C in LB medium containing 50 μg/mL kanamycin 
followed by induction with 1 mM IPTG at an OD600 of ~0.6. The cell pellet obtained 
three hours post-induction was lysed in buffer A1 using 1 mg/mL lysozyme and 
subsequent sonication. Following heat denaturation of the cell lysate at 75 °C for 15 min, 
protein purification was carried out using Ni
2+
 Sepharose affinity chromatography. 
Elutions were performed using buffer B with 20% glycerol. The eluted protein was 
further purified by size exclusion chromatography using a Superdex 75 column (GE 
Healthcare) in Buffer C. Protein quantification was performed by SDS-PAGE followed 
by densitometry using ImageJ (Schneider et al. 2012), analyzing various amounts of each 
purified protein on a 15% SDS-PAGE stained with Coomassie brilliant blue, against the 
standard curve of purified P. furiosus Cbf5. An average concentration was calculated 
from at least two independent measurements each with two to three different samples. 
The purity of the protein preparations was estimated to be between 80-90%.  
3.2.4 In vitro transcription and purification of tRNA 
In vitro transcription and purification of P. furiosus tRNA
Asp
 was carried out as 
described in Chapter 2. In brief, [
3
H]tRNA
Asp 
was in vitro transcribed by T7 RNA 
polymerase at 30 °C for 4 h using template DNA prepared by PCR from pIDT-Smart-
PftRNA
Asp
. Following the removal of template DNA by DNaseI digestion, tRNA was 
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purified by anion-exchange chromatography using a Nucleobond AX100 column 
(Machery-Nagel). tRNA was concentrated by isopropanol precipitation and a subsequent 
precipitation with ethanol to remove salt. The concentration of tRNA dissolved in water 
was measured photometrically, and the specific activity was determined by scintillation 
counting.  
3.2.5 Nitrocellulose Filtration 
Nitrocellulose filtration experiments were conducted as summarized in section 2.2.5. 
In short, 5 nM [
3
H]tRNA
Asp
 was incubated with 0 – 700 nM wild-type or 0 – 1200 nM 
Pus10 variants at 70 °C for 10 min. In the cases of the P306G, R313A, R318A, and ∆N 
variants, the incubation of tRNA with protein was extended to 30 min to allow the 
completion of product formation. The amount of tRNA retained on the filter was 
quantified by scintillation counting, and the KD was determined by fitting the data to the 
quadratic equation (as in section 2.2.5) with [RNA] = 5 nM.  
3.2.6 Tritium Release Assays  
For initial characterization of proteins, tritium release assays were performed 
essentially as described in Chapter 2 using 5 nM Pus10 wild-type or variant with 600 nM 
[
3
H]tRNA
Asp 
at 70 °C. For Michaelis-Menten titrations, either 5 nM Pus10 wild-type or 
R121A, 10 nM Pus10 ∆N, 15 nM Pus10 P306G, or 25 nM Pus10 R313A was titrated 
with increasing concentrations of [
3
H]tRNA
Asp
 (50 nM – 1500 nM). Initial velocities (v0) 
were determined from the time courses and v0/[E] were calculated for each protein. The 
data obtained by plotting v0/[E] against tRNA concentration was fit to the Michaelis-
Menten equation to determine Michaelis-Menten parameters. Further, to obtain the 
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single-turnover rate constants, tritium release assays were performed with 5 M of the 
selected protein and 600 nM [
3
H]tRNA
Asp
,
 
and the data was fit to the single-exponential 
equation (as in section 2.2.6).  
3.3 Results 
3.3.1 Selection of amino acids for Pus10 mutational analysis 
To select amino acid residues potentially involved in tRNA binding for site-directed 
mutagenesis, sequence alignments were performed using Pus10 sequences from ten 
archaeal species representing different classes of archaea and the human Pus10 sequence 
(Figure A1). P. furiosus Pus10 (388 amino acids) is much shorter in length than its 
human homolog (528 amino acids), with the majority of the amino acid residues (~90%) 
missing in P. furiosus Pus10 corresponding to the N-terminal domain. Therefore, all the 
aligned archaeal sequences show a shorter N-terminal domain compared to human Pus10. 
As described in section 3.1, the N-terminal domain shows a conserved zinc-binding motif 
and several conserved positively charged residues. To study the role of the zinc-binding 
motif, two of the four conserved cysteine residues (C16 and C19) were changed to 
alanine, which abolishes their ability to coordinate zinc. To understand the contribution 
of the conserved basic residues in binding the tRNA, three basic residues (R22, R121, 
K125) were individually substituted to alanine. Further, to examine the role of the N-
terminal domain for the function of Pus10, a deletion variant missing the entire N-
terminal domain was constructed (Pus10 ∆N). The forefinger loop in P. furiosus is also 
very short compared to the forefinger loop of human Pus10 with very low sequence 
conservation (Figure A1). However, the alignment shows a conserved aromatic residue in 
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the forefinger loop region in archaeal sequences, while the human Pus10 contains a lysine 
at this position. The phenylalanine present at this location in P. furiosus was replaced 
with alanine (F181A) to test its potential role in interacting with tRNA through base 
stacking.  
Unlike the N-terminal domain and the forefinger loop, the thumb loop is very well 
conserved and contains several basic residues. In order to understand the role of these 
conserved basic residues in the interaction with tRNA, arginines at positions 308, 313, 
and 318 were substituted with alanine. Also, a conserved proline residue located at the 
start of the thumb loop was replaced with glycine (P306G) to test if it acts as a hinge in 
accommodating the tRNA in the active site. In addition to the above discussed changes 
made in the catalytic domain, the absolutely conserved catalytic aspartate (D210) was 
substituted with asparagine, and arginine 208, located two residues prior to the catalytic 
aspartate, was substituted with alanine (R208A). The arginine at this position is 
conserved in all the known  synthase families except TruA and TruB, and is proposed 
to play a role in flipping the target uridine into the active site in RluA (Hoang et al. 
2006).  
3.3.2 Purification of Pus10 and its variants  
All the P. furiosus pus10 mutants carrying the desired nucleotide changes were 
successfully constructed using QuikChange
TM
 site-directed mutagenesis and by 
employing PCR to obtain the N-terminal deletion mutant. The resulting constructs were 
used for over-expression of proteins in E. coli, and all proteins were purified by Ni
2+
 
Sepharose affinity chromatography followed by size-exclusion chromatography. SDS-
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PAGE analysis of the purified proteins showed an intense band corresponding to the full-
length Pus10 (46.5 kDa) and a few less intense low molecular weight bands which were 
retained upon purification by size-exclusion chromatography (Figure 3.2), suggesting 
them to be degradation products of the full-length protein. Densitometry analysis carried 
out using ImageJ showed full-length Pus10 constituted more than 80% of the purified 
protein. Hence, the concentration of the protein corresponding to only the full-length 
protein was determined using SDS-PAGE and densitometry. 
 
 
Figure 3.2. Gel analysis of purified Pus10 wild-type and variants.  
50 pmol of each purified Pus10 protein was analyzed on 12% tris-tricine-PAGE and 
visualized by staining with Coomassie blue. M: Protein molecular weight marker. Each 
lane is identified with the corresponding protein sample, Pus10 wild-type (Wt) and its 
variants. Molecular weights of the proteins from the marker are labeled. 
 
3.3.3 Optimal KCl concentration for 55 formation by Pus10  
Previously, optimal buffer conditions required for tRNA modification by Cbf5 were 
determined (refer to section 2.3.1). These experiments have demonstrated that a KCl 
concentration of 150 mM is optimal for Cbf5’s in vitro  synthase activity in introducing 
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55 into tRNA. Surprisingly, Gurha and Gupta (2008) reported that P. furiosus Pus10 
forms s at non-specific sites along with position 54 and 55, when they conducted the 
experiments at 150 mM NaCl. To test if Pus10 modifies more than one site in our system, 
tritium release assays were performed at four different KCl concentrations (75 mM – 600 
mM) using 5 nM Pus10 wild-type and 600 nM [
3
H]tRNA (Figure 3.3). At the lowest KCl 
concentration used in the experiment (i.e. 75 mM), about 60%  forms in 50 min; and at 
the highest KCl concentration (i.e. 600 mM) tested, about 40%  forms in 50 min. In 
reactions performed at 150 mM KCl and 300 mM KCl, 90% and 70%  was detected, 
respectively.  
 
Figure 3.3. KCl titration of pseudouridine formation in tRNA by Pus10.  
Tritium release assays were performed with 5 nM Pus10 wild-type and 600 nM [
3
H]-
tRNA, in the presence of 75 mM KCl (half-filled circles), 150 mM KCl (filled circles), 
300 mM KCl (crossed circles), and 600 mM KCl (filled circles, dotted lines). Smooth 
curves were obtained by fitting the data to a hyperbolic equation. 
Thus the highest amount of  was observed when 150 mM KCl was used in the 
reaction, and under any tested KCl concentration the percentage of modification is not 
more than 100%. Moreover, as observed from the initial linear phase,  is formed at a 
much a higher rate in 150 mM and 300 mM KCl, compared to the reaction at 75 mM and 
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600 mM KCl. Together these data indicate that the optimal KCl concentration for tRNA 
modification by Pus10 is between 150 mM – 300 mM, and in this range there is only one 
 modified per tRNA. Based on this observation, all further experiments were performed 
with the buffer containing 150 mM KCl. 
3.3.4 Pseudouridylation activity of Pus10 wild-type and its variants 
In order to analyze the pseudouridylation ability of Pus10 wild-type, a tritium release 
assay was performed under multiple-turnover conditions using 5 nM protein and 600 nM 
[
3
H]tRNA. To monitor the course of  formation, samples were collected at various time 
points after initiating the reaction, and the amount of  was determined in each sample. 
Pus10 wild-type shows 100% conversion of uridine to  in 30 min, while 90% of the 
modification takes place within 15 min under these conditions (Figure 3.4A). From the 
linear phase, the initial rate catalyzed by wild-type Pus10 was determined to be 160 ± 20 
nM min
-1 
(Table 3.2). This analysis was also performed with all the constructed variants 
in order to study the effects of amino acid substitutions on Pus10’s ability to 
pseudouridylate tRNA. Pus10 F181A, containing the only substitution made in the 
forefinger loop, yields a time course that is very similar to the wild-type in terms of both 
end level and initial rate (140 ± 5 nM min
-1
) (Figure 3.4A, Table 3.2). As shown in 
Chapter 2 and in other published works (Ramamurthy et al. 1999a; Wright et al. 2011), 
when the absolutely conserved aspartate residue from the catalytic pocket of  synthase 
is substituted with asparagine, it abolished the catalytic activity of the enzyme in 
modifying tRNA. As predicted, substitution of the aspartate residue at position 210 of 
Pus10 with asparagine also abolishes Pus10’s ability to modify tRNA (Figure 3.4A, 
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Table 3.2). Interestingly, also the arginine to alanine replacement at position 208 renders 
Pus10 inactive, similarly to the catalytically inactive Pus10 D210N variant.  
Next, the Pus10 variants with single amino acid changes in the thumb loop were 
tested. Pus10 P306G and Pus10 R318A variants show comparable time courses, reaching 
~ 50%  formation in 30 min with similar initial rates (Figure 3.4B, Table 3.2). Pus10 
R313A results in slower  formation, i.e. 25% modification in 30 min, with an initial rate 
of 7 ± 1 nM min
-1
. Another thumb loop variant constructed in this study, Pus10 R308A 
shows almost no  formation in 60 min (Figure 3.4B, Table 3.2). In summary, all the 
thumb loop substitutions have exhibited a significant effect on their pseudouridylation 
activity with the R308A substitution having the most severe effect. 
Further analysis of the variants with substitutions in the THUMP domain was carried 
out. All these variants, excluding the N-terminal deletion variant, result in very similar 
time courses as that of Pus10 wild-type (Figure 3.4C). Hence, contrary to the thumb loop 
variants, there is no effect on the pseudouridylation activity of Pus10 due to the 
substitution of the selected basic residues in the THUMP domain, as well as the removal 
of the zinc-binding site (Table 3.2). However, the Pus10 variant lacking the N-terminal 
domain shows a significant decrease in the amount of  formed (only 40% modification 
in 60 min) and a about 36-fold decrease in the initial rate (Table 3.2). Altogether, these 
results demonstrate the importance of the residues in the thumb loop besides the catalytic 
pocket and the role of the THUMP domain as a whole for the catalytic function of Pus10 
in pseudouridylation. 
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Figure 3.4. Time courses of 55 formation in tRNA by Pus10 wild-type and 
variants.  
Tritium release assays were conducted with 5 nM protein and 600 nM [
3
H]tRNA at 70°C. 
The time courses were fit to a hyperbolic equation (smooth curves) and initial rates were 
calculated from the linear fits (not shown) of the initial linear phase. A) Time courses of 
Pus10 wild-type (filled circles), Pus10 F181A (cross), Pus10 D210N (open circles), and 
Pus10 R208A (star). B) Time courses of Pus10 wild-type (filled circles) compared to the 
variants carrying substitutions in the thumb loop; Pus10 P306G (filled squares), Pus10 
R308A (open squares), Pus10 R313A (filled triangles), and Pus10 R318A (open 
triangles). C) Time courses of Pus10 wild-type (filled circles) compared to the variants 
with substitutions in the THUMP domain: Pus10 C16AC19A (plus), Pus10 R22A (open 
diamonds), Pus10 R121A (filled diamonds), Pus10 K125A (open inverted triangles), and 
Pus10 ΔN (filled inverted triangles). 
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Table 3.2. Initial rates (v0) for pseudouridine formation by Pus10 wild-type and variants 
Region of substitution Pus10 variant v0, nM min
-1
 
 Pus10 Wild-type 160 ± 20 
Catalytic pocket 
 
Pus10 D210N nd
a
 
Pus10 R208A nd
a
 
Forefinger loop Pus10 F181A 140 ± 5 
Thumb loop 
Pus10 P306G 18 ± 4 
Pus10 R308A 0.40 ± 0.05 
Pus10 R313A 7 ± 1 
Pus10 R318A 20 ± 2 
Zinc-binding site Pus10 C16AC19A 150 ± 10 
N-terminal THUMP domain 
Pus10 R22A 140 ± 20 
Pus10 R121A 135 ± 5 
Pus10 K125A 150 ± 15 
Pus10 ∆N 4.3 ± 0.1 
a
 nd – not determined since Pus10 variant is inactive 
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3.3.5  formation by Pus10 under single-turnover conditions  
As noticed in the tritium release assays conducted under multiple-turnover conditions, 
Pus10 R208A shows no activity, indicating that the point mutation introduced at this site 
severely affected the catalytic ability of Pus10. Under the conditions used in multiple-
turnover experiments, it is difficult to know if the Pus10 R208A variant is limited to only 
a single round of catalysis given that a single round corresponds to 5 nM tRNA 
modification (i.e. less than 1%). Therefore to answer this question, tritium release assays 
were carried out using 5 M protein and 600 nM [3H]tRNA, wherein the protein only has 
to perform one round of modification corresponding to a maximum of 600 nM tRNA 
pseudouridylation. Pus10 wild-type converts about 90% of the uridine into  in 4 min, 
reaching about 80%  already in one minute, at a specific rate of 0.06 s-1 (Figure 3.5). As 
expected, the catalytically inactive variant, Pus10 D210N showed no  formation, and 
the same was true for the Pus10 R208A variant. The inability of the Pus10 R208A variant 
to form  even in the presence of excess protein confirms that the Pus10 R208A variant 
is catalytically inactive. In addition to the variants carrying changes in the catalytic 
pocket, Pus10 R308A, the other variant that also showed undetectable  formation in 
multiple-turnover experiments, was tested under single-turnover conditions. This variant 
with a mutation in the thumb loop, yielded a moderate level of  accumulation by 
converting 25% of uridine to  upon 4 min incubation (Figure 3.5). In summary, Pus10 
R308A differed from Pus10 D210N and R208A variants by showing some  formation 
while the two catalytic pocket variants exhibited no pseudouridylation activity. This 
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indicates that the pseudouridylation ability of Pus10 R308A is not completely abolished, 
although it is severely impaired.  
 
Figure 3.5. Time courses of pseudouridine formation by Pus10 under single-
turnover conditions.  
Tritium release assays were performed using 5 M protein and 600 nM tRNA. Pus10 
wild-type (filled circles), Pus10 D210N (open circles), Pus10 R208A (stars), and Pus10 
R308A (open squares). Time courses were fit to a single exponential equation to obtain 
the rate of pseudouridine formation (k). 
 
3.3.6  formation by Pus10 R308A under multiple-turnover conditions  
From the previous experiments it is not clear if Pus10 R308A is capable of performing 
multiple rounds of catalysis, which requires the ability to release the product tRNA upon 
modification. In order to determine this, tritium release assays were conducted with 200 
nM protein and 600 nM tRNA. Although Pus10 R308A could not introduce  into all the 
tRNA molecules, it modified about 65% of the tRNA in 60 minutes i.e. it performed 
close to 2 rounds of catalysis (Figure 3.6). This result demonstrates that Pus10 R308A is 
not limited in product release as it can perform more than a single round of catalysis, but 
the slower rate of  formation under both multiple and single-turnover conditions 
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confirms that the R308A substitution in the thumb loop severely affects Pus10’s catalytic 
ability.     
 
Figure 3.6. Pseudouridylation of tRNA by Pus10 R308A under multiple-turnover 
conditions.  
Tritium release assays were performed with 200 nM Pus10 R308A and 600 nM tRNA. 
The smooth curve was obtained by fitting the time course to a hyperbolic equation.  
 
3.3.7 Investigating the effect of amino acid changes on tRNA binding by Pus10  
One of the questions we would like to answer in this work is what regions of Pus10 
mediate the interaction with tRNA. To address this question, analysis of all the 
constructed variants in comparison to the Pus10 wild-type was conducted by 
nitrocellulose filtration experiments that allowed us to determine the dissociation 
constants (KDs) for binding of Pus10 to tRNA. [
3
H]tRNA was incubated with increasing 
concentrations of either Pus10 wild-type or variant at 70 °C for 10 min. The minimum 
protein concentration employed in the experiment was at least three-fold higher than the 
concentration of the tRNA. Under these conditions, most of the tRNA molecules are 
pseudouridylated, therefore the KD measured here reflects the KD for the product tRNA. 
In the cases of the thumb loop and ∆N variants that showed slower rates of  formation, 
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the incubation step was extended to 30 min to allow the completion of the tRNA 
modification. The Pus10 variants, R208A and D210N were not subjected to this 
prolonged incubation as they are inactive. When tRNA was titrated with Pus10 wild-type, 
about 45% of tRNA was retained on the filter at saturating protein concentrations (Figure 
3.7). For most Pus10 variants, the plateau was observed at about 30% of tRNA binding. 
These low retention efficiencies of RNA in nitrocellulose filtration experiments are not 
uncommon, and might result from variations in RNA refolding, from the washing step 
performed to remove unspecifically bound RNA also removing some RNA from the 
active site, and variations in different RNA preparations (Hall and Kranz 1999; 
Ramamurthy et al. 1999a). However, it is important to note that the end levels remained 
constant in the repetitions, and the KDs were reproducible.  
Fitting the data to the quadratic equation function, yielded a KD of 30 nM for Pus10 
wild-type binding to tRNA (Table 3.3). To allow us to determine the KD for the Pus10 
interaction with the substrate tRNA, the catalytically inactive variant, Pus10 D210N was 
tested and resulted in an identical KD (29 nM) to that of the product tRNA. Next, the 
analysis was performed with the constructs carrying the substitutions in the catalytic 
pocket, forefinger loop, thumb loop, and the THUMP domain. As summarized in Table 
3.3, both Pus10 R208A carrying a substitution in the catalytic pocket and Pus10 F181A 
with a substitution in the forefinger loop exhibit very similar KDs to the wild-type. All the 
variants with changes in the thumb loop show slightly higher KDs (two- to five-fold). 
Interestingly, the variants carrying changes in the N-terminal domain result in KDs that 
are five to seven-fold higher than the KD obtained for Pus10 wild-type, with the exception 
of the Pus10 C16AC19A variant, which shows just over a three-fold increase. 
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Figure 3.7. tRNA titration with Pus10 wild-type and Pus10 variants to determine the 
affinities between Pus10 and tRNA.  
Nitrocellulose filtration experiments were conducted with 5 nM [
3
H]tRNA and increasing 
concentrations of protein. Reaction mixtures were incubated for at least 10 min at 70 °C 
prior to the filtration. Smooth curves were obtained by fitting the data to a quadratic 
equation. A) Binding curves of Pus10 wild-type (filled circles), Pus10 F181A (cross), 
Pus10 D210N (open circles), and Pus10 R208A (star). B) Binding curves of Pus10 wild-
type (filled circles) compared to the variants carrying selected substitution in the thumb 
loop; Pus10 P306G (filled squares), Pus10 R308A (open squares), Pus10 R313A (filled 
triangles), and Pus10 R318A (open triangles). C) Binding curves of Pus10 wild-type 
(filled circles) compared to the variants with selected substitution in the THUMP domain: 
Pus10 C16AC19A (plus), Pus10 R22A (open diamonds), Pus10 R121A (filled 
diamonds), Pus10 K125A (open inverted triangles), and Pus10 ΔN (filled inverted 
triangles). 
 90 
Table 3.3. Equilibrium dissociation constants for the interaction between Pus10 and 
tRNA
a
 
Region of substitution Pus10 variant KD, nM 
 Pus10 Wild-type 30 ± 10 
Catalytic pocket 
 
Pus10 D210N 29 ± 15 
Pus10 R208A 50 ± 25 
Forefinger loop Pus10 F181A 33 ± 20 
Thumb loop 
Pus10 P306G 70 ± 30 
Pus10 R308A 50 ± 25 
Pus10 R313A 140 ± 55 
Pus10 R318A 85 ± 25 
Zinc-binding site Pus10 C16AC19A 110 ± 30 
N-terminal THUMP domain 
Pus10 R22A 170 ± 45 
Pus10 R121A 160 ± 60 
Pus10 K125A 200 ± 50 
Pus10 ∆N 190 ± 65 
a 
KDs provided here are averages from at least two independent nitrocellulose filtration 
experiments reported with the highest standard deviation observed.  
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Notably, deletion of the N-terminal domain had a similar effect on the KD as the three 
single-residue substitutions (R22A, R121A, K125A) studied in the N-terminal domain 
(Table 3.3). In summary, the nitrocellulose filtration experiments revealed a tight 
interaction between Pus10 and tRNA with a low nanomolar KD. Pus10 binds both 
substrate tRNA and product tRNA with the same affinity. While the selected 
substitutions in the thumb loop have relatively moderate effects on Pus10’s interaction 
with the tRNA, changes in the N-terminal domain had a significantly larger influence. 
3.3.8 Steady-state kinetic analysis of Pus10 wild-type and selected Pus10 variants 
To gain insight into the catalytic efficiency of Pus10 wild-type and the interaction of 
Pus10 with tRNA, steady-state kinetic analysis was performed. Further, to probe the 
effect of the single residue changes introduced into Pus10, selected variants carrying 
substitutions in the thumb loop (P306G and R313A) and the THUMP domain (R121A) 
along with the N-terminal deletion variant were also analyzed by steady-state kinetic 
experiments. Low nanomolar concentrations of Pus10 wild-type or the Pus10 variants 
were incubated with increasing concentrations of tRNA in tritium release assays and 
initial rates at each tRNA concentration were determined (Figure 3.8A). To provide an 
expression that is independent of the enzyme concentration used in the experiment,   
initial rates over the enzyme concentration (v0/[E]) was calculated. Data from v0/[E] 
plotted against the respective tRNA concentration were fit to the Michaelis-Menten 
equation to determine the kcat and KM values (Figure 3.8B and C). All tested proteins have 
shown a gradual increase in v0/[E]  with increasing tRNA concentration, which saturates 
at tRNA concentrations higher than 1 M, with the exception of Pus10 ∆N. This analysis 
yielded a kcat of 0.9 s
-1 
and a KM of 400 nM for Pus10 wild-type.  
 92 
 
Figure 3.8. Steady-state kinetics of pseudouridylation by Pus10 wild-type and 
selected Pus10 variants.  
Tritium release assays were performed with low nanomolar concentrations of protein 
(refer to the methods for details) and increasing concentrations of [
3
H]tRNA at 70 °C. A) 
Representative short time courses of Pus10 wild-type that were used to calculate the 
initial velocities. 5 nM Pus10 wild-type was incubated with various concentrations of 
tRNA, 100 nM (filled circles), 400 nM (half filled circles), 1000 nM (filled circles, 
dashed lines), and 1500 nM (filled circles, dotted lines). Data were fit to a linear 
equation. B) Michaelis-Menten titration of Pus10 wild-type (filled circles) and Pus10 
R121A (filled diamonds). The v0/[E] values were calculated at each tested tRNA 
concentration by dividing the initial velocities by the concentration of enzyme used in the 
experiment. C) Michaelis-Menten titration of Pus10 P306G (filled squares), Pus10 
R313A (filled triangles), and Pus10 ΔN (filled inverted triangles). 
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The Pus10 R121A variant with the substitution in the THUMP domain exhibits a very 
similar kcat as the wild-type, but about a three-fold higher KM (Table 3.4).  
In contrast, both analyzed thumb loop variants (Pus10 P306G and Pus10 R313A) 
showed more than a twenty-fold reduction in the kcat, but only a two-fold increase in the 
KM (Figure 3.8C; Table 3.4). Interestingly, incubation of the N-terminal deletion variant 
with increasing concentrations of tRNA displays only a slight increase in v0/[E] at low 
tRNA concentrations, with no further enhancement in v0/[E] at higher tRNA 
concentrations. Owing to this behaviour observed for Pus10 ∆N, the KM could only be 
estimated for this variant. Overall, the N-terminal deletion variant results in a kcat that is 
similar to Pus10 P306G and Pus10 R313A, but thirty-fold smaller than the wild-type kcat 
(Table 3.4), and a KM that is at least six-fold smaller than the wild-type KM. 
Table 3.4. Summary of steady-state kinetic parameters of Pus10 and its variants 
Region of 
substitution 
Pus10 variant KM, nM kcat, s
-1
 
 Pus10 Wild-type 400 ± 40 0.90 ± 0.03 
Thumb loop 
Pus10 P306G 800 ± 170 0.040 ± 0.004 
Pus10 R313A 1000 ± 190 0.040 ± 0.004 
N-terminal domain 
Pus10 R121A 1100 ± 350 1.2 ± 0.2 
Pus10 ∆N < 65 0.030 ± 0.001 
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3.4 Discussion 
Most of our current knowledge on Pus10 is limited to the structural information 
available through the crystal structure of human Pus10 determined in the absence of the 
tRNA (McCleverty et al. 2007) and to the target site of archaeal Pus10 i.e. 55 in tRNA 
both in vitro and in vivo (Roovers et al. 2006; Gurha and Gupta 2008; Blaby et al. 2011). 
To understand the structure-function relationship of Pus10, with an emphasis on Pus10 
interaction with tRNA, a kinetic and thermodynamic analysis of several Pus10 variants 
carrying amino acid residue changes in key structural regions of Pus10 was conducted. 
Results from these studies demonstrate that Pus10 efficiently modifies tRNA using its N-
terminal THUMP domain and conserved thumb loop for binding and catalysis. This study 
presents the first quantitative analysis of tRNA modification by Pus10. 
In light of the observation made by Gurha and Gupta (2008), which reported Pus10’s 
ability to target both uridines at positions 54 and 55 in Haloferax volcanii tRNA with 
additional non-specific uridine conversion when buffer containing 150 mM NaCl was 
used, here the  formation by P. furiosus Pus10 at various KCl concentrations was tested. 
The results from these experiments show that 150 mM to 300 mM KCl is optimal for this 
reaction, and there is only one site modified under the reaction conditions used. The 
contrasting results obtained by Gurha and Gupta (2008) could be attributed to the use of a 
heterologous system containing P. furiosus Pus10 and H. volcanii tRNA
Trp
 in their 
studies. Here both Pus10 and tRNA substrate from P. furiosus were used, which may 
explain the higher specificity observed in these experiments. The observation that P. 
furiosus tRNA contains no  at position 54, but another modification of uridine, S2m5U 
(Kowalak et al. 1994), and the detection of s at position 55 (but not at 54), when in vitro 
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transcribed yeast and H. volcanii tRNAs were incubated with P. furiosus cell-free extract 
(Constantinesco et al. 1999), both suggests it is likely that U55 is modified. 
Time courses conducted with a large excess of substrate over enzyme revealed for the 
first time that Pus10 is a multiple-turnover enzyme. As predicted, substitution of the 
aspartate residue in the catalytic pocket with asparagine confirmed that D210 is the 
catalytic residue since Pus10 becomes inactive upon its substitution. Nitrocellulose 
filtration experiments demonstrated that despite the lack of pseudouridylation ability, 
Pus10 D210N can tightly bind tRNA with a low nanomolar affinity. Pus10 binds both the 
substrate and the modified product tRNA with similar affinity, as seen with TruB and 
Cbf5-Nop10-Gar1 (Wright et al. 2011; Kamalampeta and Kothe 2012). The catalytic 
efficiencies (kcat/KM) calculated from the values obtained by steady-state kinetic analysis 
offer insight into the modification of tRNA at position 55 by Pus10 compared to Cbf5-
Nop10-Gar1. Pus10 displays a catalytic efficiency of 2.2 x 10
6
  M
-1
 s
-1 
that is about 
thirteen-fold higher than the catalytic efficiencies calculated for P. furiosus Cbf5-Nop10-
Gar1 (1.75 x 10
5
 M
-1
 s
-1
)
 
using the data obtained in our previous work (Kamalampeta and 
Kothe 2012). As both Pus10 and Cbf5-Nop10-Gar1 exhibit similar kcat values (0.9 s
-1
 and 
0.7 s
-1
, respectively), the difference in their efficiency stems from the ten-fold difference 
in their KM values. These data provide the reason for Pus10 being the 55 synthase in 
vivo but not the Cbf5-Nop10-Gar1 complex, which is usually involved in rRNA 
modification in a guide-RNA dependent manner. It is important to note that the kcat value 
for Pus10 is similar to those reported for other stand-alone  synthases from bacteria, 
which indicates that Pus10 might also display a slow catalytic step as described for TruB, 
TruA, and RluA (Wright et al. 2011), suggesting a similar catalytic mechanism employed 
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by Pus10 in  formation. Surprisingly, the single-turnover rate of  formation (k) 
measured for Pus10 is about fifteen-fold lower than the kcat. kis the rate of  formation 
in a single round whereas kcat is the rate of a multiple-turnover reaction, which consists of 
all the steps as in single round and in addition a product release step. So, fundamentally 
kcannot be lower than the kcat. The reason for such a low rate in presence of high 
enzyme concentrations is not known. Further investigation is needed to identify the 
problem in these experiments.     
A sequence alignment of bacterial  synthases along with Pus10 (McCleverty et al. 
2007) revealed an arginine residue, two amino acids N-terminal to the catalytic aspartate, 
that is conserved in all  synthases except in TruB and TruD. An arginine to alanine 
substitution at this position (Pus10 R208A) has no effect on Pus10’s affinity for tRNA 
(Table 3.3), but abolishes the catalytic activity, demonstrating an essential role of R208 
for the catalytic function of Pus10. It is likely that this arginine residue is involved in 
flipping the target uridine into the active site during the modification, similarly to the role 
suggested for the arginine found in RluA in a structurally equivalent position (Hoang et 
al. 2006). In this work, the authors showed that neither methionine, nor lysine could be 
substituted for the arginine without abolishing pseudouridylation activity, indicating the 
importance of arginine at this position. Although the bacterial 55 synthase, TruB, does 
not contain arginine at this position, histidine 43 was proposed to play a similar role in 
promoting the base flipping during the modification of U55 (Hoang and Ferré-D'Amaré 
2001). In summary, besides the other three catalytic residues (D210, Y274, K348 in 
Pus10) that are conserved in  synthases, R208 is also essential for the Pus10 catalyzed 
 97 
tRNA modification. Further studies are required to prove the role of R208 in placing the 
target uridine in the active site.  
The N-terminal THUMP domain in Pus10 is only found in this  synthase family 
similar to other accessory, family-specific domains found in other  synthases. Since the 
accessory domains in the other families of  synthases are involved in RNA binding and 
since the THUMP domain is present in several RNA modifying enzymes, it has been 
suggested that Pus10’s THUMP domain is involved in facilitating RNA binding (Aravind 
and Koonin 2001; McCleverty et al. 2007). Besides this hypothesis, a model created by 
manually docking tRNA onto Pus10 suggested that the conserved basic residues in the 
THUMP domain are likely involved in accommodating tRNA (McCleverty et al. 2007). 
Three Pus10 constructs created in this work by individually substituting conserved basic 
residues in the THUMP domain all show a  significantly reduced affinity for tRNA 
compared to wild-type Pus10 (Table 3.3), confirming the role of the N-terminal domain 
in interacting with tRNA. None of these Pus10 variants have any effect on the 
pseudouridylation activity of Pus10 due to the higher substrate concentrations (about 
three-fold over their KD) used in these experiments (Figure 3.4C). In addition to these 
results, the steady-state parameters determined for Pus10 R121A revealed a similar kcat to 
wild-type, but a two-fold higher Michaelis-Menten constant (Table 3.4), which further 
supported the effect of these substitutions on tRNA binding but not on the catalytic 
activity. Interestingly, the N-terminal deletion variant also displayed a similar effect on 
affinity for tRNA as observed with single amino acid substitutions of the basic residues 
from this domain. This implies that the conserved basic residues in the THUMP domain 
are the main contacts for the interaction with tRNA. Furthermore, the deletion of the 
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entire THUMP domain severely affected Pus10’s catalytic activity, yielding a thirty-fold 
lower kcat compared to wild-type Pus10 (Table 3.4). Such a significant consequence of 
the N-terminal deletion on the catalytic ability of Pus10 further suggests an important 
role for the THUMP domain in augmenting the functional ability of Pus10 in 
pseudouridylating tRNA. This role of the THUMP domain may be accomplished through 
proper positioning of tRNA into the catalytic pocket. The presence of a much longer 
THUMP sequence found in higher eukaryotes, together with some remarkably identical 
regions identified in Drosophila melanogaster and humans (McCleverty et al. 2007) may 
point towards a role of the THUMP domain in other functions of Pus10 observed in 
humans such as a function in TRAIL induced apoptosis (Park et al. 2009). 
Analysis of the double variant (Pus10 C16AC19A), created to eliminate zinc binding 
by Pus10, revealed only a small effect (three-fold reduction) on the affinity of Pus10 for 
tRNA, with no effect on the catalytic activity of Pus10, indicating that the zinc-binding 
motif is not required for the catalytic function of Pus10. This finding is in contrast to the 
studies on a yeast  synthase, Pus1, where the zinc ion is essential for Pus1 binding to 
tRNA in vitro and hence for the catalytic function of the enzyme (Arluison et al. 1998). 
Nevertheless, it is possible that the zinc-binding motif of Pus10 may have a role in the 
cell that is not essential for the pseudouridylation activity in the purified in vitro system. 
Lastly, the four thumb loop variants investigated in this work, each with a single 
amino acid substitution, all display minor effects on the affinity for tRNA. But, they all 
show significantly reduced initial rates in pseudouridylation with the most severe effect 
resulting from the R308A substitution. Time courses performed with Pus10 R308A in the 
presence of high concentrations of enzyme revealed that its catalytic activity is severely 
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impaired. The multiple-turnover assay indicated that this variant is not limited in product 
release. Together, these results confirmed that R308 is very important for the catalytic 
activity of Pus10. The steady-state kinetic data obtained for Pus10 P306G and Pus10 
R313A showed an over twenty-fold reduction in kcat, further supporting the effect on the 
catalytic activity due to substitutions in the thumb loop. A slight increase in KM values 
(about two-fold) observed for these two variants also correspond well with the similar 
effects seen on the KDs. In summary, the results obtained with the thumb loop variants 
confirm that the conserved basic residues in this loop play a critical role in the catalytic 
function of Pus10. It is not clear from these experiments whether the positive charge of 
the arginine or the specific arginine side chain is important for its role. Future 
experiments with Pus10 variants carrying substitutions of the arginines with methionine 
and lysine could clarify this question. As proposed for TruB (Hoang et al. 2005), the 
thumb loop may contribute to the stabilization of the interaction of tRNA with Pus10.  
In contrast to the important role of the thumb loop, the single phenylalanine (F181) 
residue we studied from the forefinger loop did not show any contribution towards either 
tRNA binding or catalysis. This finding can be attributed to the poor conservation 
observed in this structural element, which may indicate a less significant role of this loop 
in Pus10 function.  
In conclusion, the first quantitative studies reported here on tRNA modification by 
Pus10 provide evidence for the important role of the THUMP domain and the thumb loop 
in this reaction. This work also establishes the critical contribution of arginine 208 in 
Pus10 catalytic activity. Our studies also provide a reason why Pus10 is the archaeal in 
vivo 55 synthase, despite the existence of Cbf5 in the cell. Further, we propose that 
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Pus10 follows an induced-fit mechanism in binding the tRNA, similar to TruB (Pan et al. 
2003). In this work, by comparing the structures of TruB alone and with that of a TruB 
bound to RNA, the authors suggested that TruB uses an induced fit mechanism wherein it 
undergoes a conformational change upon initial binding to enhance the interaction with 
tRNA. In a similar manner, in the case of Pus10, initial docking of tRNA may take place 
with the help of the THUMP domain followed by the interaction of the thumb loop which 
undergoes a conformational change. Then both the THUMP domain and the thumb loop 
facilitate the correct positioning of tRNA in the active site followed by a conformational 
change in the active site, wherein arginine 208 probably promotes the flipping of the 
target nucleotide for catalysis.           
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Chapter 4: Conclusions and future perspectives 
Even though pseudouridine was identified over 50 years ago, its actual function in the 
cell and the molecular mechanism underlying the modification are yet to be known. 
Undoubtedly, significant progress has been made in the last one and a half decade which 
is mainly dominated by the knowledge obtained from the structural studies and 
biochemical analysis of  synthases (Hamma and Ferré-D'Amaré 2006; Grosjean and 
Ferré-D'Amaré 2009). Besides gaining more insight into the structure and function of  
synthases, these studies also raised new questions. One such case is the  synthase Cbf5 
that evolved to function together with H/ACA RNA to create the relatively large number 
of modifications found in archaea and eukaryotes. Interestingly, being a homolog to 
TruB, a stand-alone  synthase, Cbf5 also retained its ability to introduce the 55 in 
archaeal tRNAs (Roovers et al. 2006). In this thesis, studies on the contribution of two 
accessory proteins, Nop10 and Gar1, revealed that they exert a two-fold activating effect 
on guide RNA-independent activity of Cbf5 by increasing the affinity of Cbf5 for tRNA 
and by enhancing its catalytic ability. The catalytic rates determined for the guide-RNA-
independent modification by Cbf5 indicated that by forming a ternary complex with 
Nop10 and Gar1 proteins, Cbf5 attains a similar efficiency as other stand-alone  
synthases. Some of these findings are likely applicable to the guide-RNA-dependent 
activity of H/ACA sRNPs (see section 2.4 for detailed discussion). Although results from 
this work establish the basis for the ability of Cbf5 to modify tRNA under in vitro 
conditions, it is not clear if the cell has any advantage for retaining this ability of Cbf5 as 
Cbf5 appears to be mainly involved in guide-RNA-dependent pseudouridine formation in 
the cell (Blaby et al. 2011).  In general, observations in this work indicate how an 
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enzyme’s dependency on partner proteins for attaining the catalytic efficiency can act as 
a means of regulation. It can be envisioned that inherently unstable Cbf5 in the cell 
becomes fully active only when its partner proteins are present, which in turn may be 
involved in the coordination of other related activities in the cell.  
I also made attempts to purify the functional H/ACA sRNP complex from P. furiosus, 
but only a partially active complex has been obtained that could not be used for kinetic 
studies of the guide RNA-dependent function of Cbf5. Very recently, Ye and colleagues 
published the kinetic analysis of a short synthetic substrate RNA modification by P. 
furiosus H/ACA sRNP complex (Yang et al. 2012). However, the experiments were 
performed at 37 ˚C while the optimal temperature for Cbf5-catalyzed tRNA modification 
under in vitro conditions is 70 ˚C (Roovers et al. 2006), which is similar to the 
physiological temperature of P. furiosus (~100 ˚C). In future, it will be useful to carry out 
the steady-state kinetic analysis at this reported optimal temperature for Cbf5 to obtain a 
relevant kcat which would allow a comparison of the catalytic efficiencies of Cbf5 in 
guide RNA-independent and -dependent functions. Further, to confirm the involvement 
of the residues proposed in mediating the roles of Nop10 and Gar1 (Figure 2.7), 
individual Cbf5, Nop10, and Gar1 variants carrying substitutions in these amino acids 
can be constructed and analyzed in both guide-RNA-dependent and -independent 
reactions.  
Initially it was not known if Cbf5 or Pus10 is responsible for the 55 formation in 
archaeal tRNAs. During the course of my thesis, however, it has been shown that Pus10 
performs the in vivo modification of 55 in tRNAs in archaea (Blaby et al. 2011). In this 
thesis, thermodynamic and kinetic studies of Pus10 variants carrying selected amino acid 
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substitutions in various structural regions of the protein allowed me to identify several 
key residues and their contributions to tRNA binding and catalysis. Most interestingly, 
this work demonstrated the important role of conserved amino acids in the thumb loop of 
Pus10 for catalysis and potential contributions of the unique THUMP domain to tRNA 
binding. Another key finding from this work is the identification of a new catalytic 
arginine residue located close to the catalytic aspartate. Pus10 is one of the two known 
synthases to contain a zinc ion. In contrast to the essential role of zinc in the case of 
the yeast pseudouridine synthase Pus1p (TruA family) (Arluison et al. 1998), studies 
from this thesis indicate no obvious need for zinc in in vitro modification reaction by 
Pus10. It is possible that zinc plays a structural role in Pus10. 
Consistent with Pus10’s function in tRNA modification in vivo, Michaelis-Menten 
parameters determined in this work indicated a higher catalytic efficiency of Pus10 
compared to the Cbf5-Nop10-Gar1 complex. Further, the finding that Pus10 displays a 
similar kcat as other known synthases also strengthens the argument that pseudouridine 
synthases employ the same catalytic mechanism. In summary, besides the insight into the 
unexpected function of Cbf5 in tRNA modification, this work provides the first 
quantitative biochemical analysis of Pus10 and opens the way for further findings that 
will enhance our understanding of this new synthase family. This work also extends 
our understanding of enzymes involved in tRNA modification, in general. 
In future, it will be interesting to confirm the suggested role of the newly identified 
catalytic arginine residue in base-flipping. One way of confirming this is to use tRNA 
with a fluorescent label in the TC arm to perform a titration with wild-type Pus10 and 
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with the Pus10 variant carrying a substitution for arginine 208. A change in fluorescence 
reflecting base-flipping in the case of wild-type Pus10 that is absent in the arginine 208 
variant would provide evidence for its role in base-flipping. Further, to support the 
contribution of the THUMP domain in tRNA binding, a cocrystal structure of Pus10 and 
tRNA can be determined which will, in addition, provide insight into the interaction of 
Pus10 and tRNA. As noticed there is a discrepancy in the literature regarding the site of 
modification of tRNA by Pus10 which can modify either position 55 or uridine 54 as 
reported in a halophile (Gurha and Gupta 2008). To confirm if P. furiosus Pus10 only 
introduces 55 under the tested conditions, a control tRNA containing a substitution at 
position 55 (Roovers et al. 2006) can be used in tritium release assays to clarify this 
confusion. Besides these proposed studies, solving the kinetic mechanism of Pus10-
catalyzed tRNA modification will further extend our knowledge of this novel synthase. 
Towards solving the chemical mechanism of formation, there is a need for a 
comprehensive understanding of the substrate recognition by synthases. To this end, 
solving cocrystal structures for remaining representative synthases may prove to be 
useful. Also, biochemical studies involving mutational analysis of substrates to identify 
the key determinants of protein-RNA interactions and the minimal substrate requirements 
will be informative. Experimental techniques to monitor the conformational changes in 
real time such as stopped-flow may be helpful in gaining further understanding into the 
enzyme and substrate interactions. Together, a careful integration of knowledge obtained 
using structural studies combined with biochemical analysis may eventually reveal the 
chemical mechanism of this deceptively simple modification.  Finally, to understand the 
actual role of s there is a need to distinguish the other biological roles of synthases 
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from that of the modification, which requires considerable further efforts to design both 
in vivo and in vitro studies. Given the extent of progress achieved in last one and a half 
decade one can be optimistic about solving these puzzles in the very near future.  
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Figure A1: Alignment of Pus10 protein sequences from human and selected archaeal species.  
The alignment was performed using ClustalW with Pus10 sequences representing different classes of archaea and human. Each 
sequence is labeled with the respective UniProt identification number. Conserved motifs, thumb loop and forefinger loop sequences in 
the catalytic domain are highlighted. Conserved residues are highlighted (black: 100%, grey: >75%). Iag: Ignisphaera aggregans, 
Tag: Thermosphaera aggregans, Ape: Aeropyrum pernix, Tac: Thermoplasma acidophilum, Mja: Methanococcus jannaschii, Mfe: 
Methanocaldococcus fervens, Pfu: Pyrococcus furiosus, Mka: Methanopyrus kandleri, Afu: Archaeoglobus fulgidus, Kcr: 
Korarchaeum cryptofilum, and Hsa: Homo sapiens. 
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